143 min read

Part V · Continuity  ·  Estimated reading time 105 minutes  ·  Prerequisites: Chapters 3, 16, 19, 27

28. Pregnancy and Human Development

From Fertilization to Birth

Part V · Continuity  ·  Estimated reading time 105 minutes  ·  Prerequisites: Chapters 3, 16, 19, 27


Case File 28 — "The Organ That Is Meant to Be Thrown Away"

Nia Osei-Barrett, 24, arrives for her first prenatal visit at 11 weeks' gestation. She is a physical therapy student and a competitive distance runner — a 3:04 marathon eighteen months ago — and she has been running four to five days a week throughout the first trimester. She feels well apart from morning nausea that peaked two weeks ago and is now fading.

Booking visit — 11 weeks Value Non-pregnant adult range
Blood pressure 108/64 mm Hg < 120/80
Heart rate 76 beats/min 60–100
Hemoglobin 11.6 g/dL 12.0–15.5 (non-pregnant female)
Hematocrit 35% 36–46%
Serum creatinine 0.6 mg/dL 0.6–1.1
Urine protein : creatinine 0.06 < 0.15
Body mass index (pre-pregnancy) 21.4

Her obstetrician takes a family history and stops at the second line of it. Nia's mother, Amara Osei, 45, has hypertension, established coronary artery disease, type 2 diabetes, and stage 3 chronic kidney disease. Nia's grandmother, Adwoa Mensah, 78, has hypertension. Nia is in her first pregnancy.

That combination — a first pregnancy plus a first-degree relative with hypertension and renal disease — places her in a risk category for preeclampsia, and she is started on low-dose aspirin, 81 mg daily, at 12 weeks.

By 28 weeks she is thriving. She has also changed, systematically, in ways that would be alarming in anyone who was not pregnant:

28 weeks Value Change from booking
Blood pressure 102/58 mm Hg
Heart rate 88 beats/min ↑ 12
Hemoglobin 10.9 g/dL ↓ 0.7
Estimated plasma volume +45% above pre-pregnancy ↑↑
Estimated cardiac output ~6.9 L/min (from ~4.9) ↑ ~40%
Serum creatinine 0.5 mg/dL

Three questions to hold on to.

  1. Why does pregnancy raise cardiac output by roughly 40%? What, specifically, needs the extra flow — and how does a heart that was already working perfectly well produce it?
  2. Why does hemoglobin fall in a completely healthy pregnancy, at a time when the woman is manufacturing red blood cells faster than she ever has in her adult life?
  3. How can a disease of the placenta — a temporary organ that will be delivered, weighed, and discarded within an hour of the baby — cause high blood pressure, kidney damage, liver injury, and seizures in the mother?

Learning Objectives

By the end of this chapter you should be able to:

  1. Describe sperm transport and capacitation, and explain why a freshly ejaculated sperm cannot fertilize an oocyte.
  2. Sequence the events of fertilization from corona radiata penetration through syngamy, and explain the fast and slow blocks to polyspermy.
  3. Trace cleavage from zygote to blastocyst, and distinguish the fates of trophoblast and inner cell mass.
  4. Describe implantation and the formation of the bilaminar disc, amnion, and yolk sac.
  5. Explain how the timing of splitting determines chorionicity and amnionicity in monozygotic twins.
  6. Describe the structure of the placenta and its four functions, and identify precisely what separates maternal from fetal blood.
  7. Explain why the umbilical arteries carry deoxygenated blood and the umbilical vein carries oxygenated blood.
  8. Name the three germ layers, list their principal derivatives, and predict which structures are affected by a defect arising in each.
  9. Explain neurulation and relate the timing of neuropore closure to neural tube defects.
  10. Define a critical period and use a teratogen susceptibility timeline to predict which organ is at risk from an exposure at a given gestational week.
  11. Diagram the fetal circulation, identify the three shunts, state the oxygen saturation at each point, and explain why each shunt exists.
  12. Explain the sequence of circulatory changes at birth and what each shunt becomes.
  13. Quantify the major maternal adaptations — cardiovascular, respiratory, renal, gastrointestinal, musculoskeletal, integumentary, and metabolic — and give the mechanism of each.
  14. Explain the physiologic anemia of pregnancy and why it is a sign of health.
  15. Describe the initiation of labor and diagram the oxytocin positive feedback loop.
  16. Contrast the prolactin and oxytocin reflexes of lactation.
  17. Explain preeclampsia as a placental disease producing systemic endothelial dysfunction, and account for each of its clinical features.
  18. Explain the developmental origins of adult disease and relate them to the Osei family.

28.1 Fertilization

A human pregnancy begins with a meeting that is, statistically, extremely unlikely and, mechanically, extremely well engineered. Understanding it requires holding two facts at once: the egg is enormous and passive, and the sperm is tiny, numerous, and disposable.

The secondary oocyte released at ovulation (§27.6) is about 120 micrometers across — the largest cell in the human body, just visible to the naked eye. It carries essentially the entire cytoplasmic inheritance of the future organism: mitochondria, ribosomes, messenger RNAs, and the machinery that will run the first several cell divisions. A spermatozoon is about 60 micrometers long, and virtually all of that is tail. Its head is 5 micrometers of condensed DNA with a cap on it. It contributes a haploid genome, a centriole, and almost nothing else.

Sperm transport

Ejaculation deposits 200–300 million sperm in the posterior vaginal fornix. Fewer than 200 — roughly one in a million — reach the ampulla of the uterine tube where fertilization occurs. The attrition is not incidental; it is a filter.

  • The vagina is hostile. Vaginal pH is 3.8–4.5, maintained by lactobacilli, and sperm are immobilized below about pH 6.0. Seminal plasma is alkaline (pH 7.2–7.8) and buffers a transient window of survivability lasting a few minutes. Sperm that have not entered cervical mucus within roughly 30 minutes will not.
  • The cervix selects. Under the estrogen dominance of the late follicular phase, cervical mucus becomes thin, watery, and organized into parallel micelles that channel motile sperm upward — the property clinicians call spinnbarkeit. Under progesterone, the same mucus becomes thick and disorganized and is essentially impassable. This is one of the mechanisms by which progestin contraception works.
  • The uterus assists. Prostaglandins in seminal plasma, and oxytocin released during female orgasm, stimulate myometrial contractions that create pressure waves transporting sperm passively. Sperm have been recovered from the uterine tube within five minutes of insemination — far faster than their own swimming speed of about 3 mm/min could carry them. Those first arrivals, however, are usually not yet able to fertilize.
  • The uterotubal junction is a reservoir. Sperm bind loosely to the tubal epithelium and are released in waves over the next several days. This stretches the window of fertility so it does not depend on a single lucky coincidence of timing.

The arithmetic of that window is worth memorizing. A sperm remains fertile in the female tract for 3–5 days (occasionally 7). An oocyte remains fertilizable for 12–24 hours after ovulation. The fertile window is therefore about six days long and ends on the day of ovulation — which is why fertility awareness methods must predict ovulation rather than detect it.

Capacitation

A sperm taken straight from the ejaculate and placed next to an oocyte will not fertilize it. It must first undergo capacitation, a 6–8 hour maturation that occurs only in the female reproductive tract (or, for in vitro fertilization, in a culture medium designed to mimic it).

Three things happen:

  1. Cholesterol and seminal glycoproteins are stripped from the sperm plasma membrane by albumin and other components of tubal fluid. The membrane becomes more fluid and destabilized — primed to fuse.
  2. Calcium and bicarbonate permeability rises, raising intracellular pH and activating a soluble adenylyl cyclase. Protein tyrosine phosphorylation increases throughout the tail.
  3. Motility changes character. The regular, forward-progressive beat becomes hyperactivated: a high-amplitude, whip-like, almost thrashing motion. This looks less efficient, and in open fluid it is. Its purpose is mechanical — it generates the force needed to detach from the tubal epithelium and to drill through the coverings of the egg.

Capacitation is best thought of as arming a device. It is deliberately delayed so that the acrosome — a bag of digestive enzymes — is not discharged prematurely in the vagina or uterus, where it would accomplish nothing.

The oocyte's coverings

The oocyte arrives at the ampulla wearing two layers.

  • The corona radiata is the outermost: two to three cell layers of granulosa cells left over from the ovarian follicle, embedded in a matrix of hyaluronic acid. It is thick, sticky, and mechanically substantial.
  • The zona pellucida lies beneath it: a translucent glycoprotein shell about 13 micrometers thick, built from four glycoproteins (ZP1–ZP4). It is species-specific, it is the sperm's binding target, and after fertilization it becomes the wall that prevents any further sperm from entering.

Sperm cross the corona using surface-bound hyaluronidase (the enzyme PH-20, displayed on the sperm head after capacitation) together with the mechanical force of hyperactivated motility. This is a group effort: hundreds of sperm loosen the matrix, and the one that eventually fuses is usually not the first to arrive.

The acrosomal reaction

Contact with the zona pellucida — principally with ZP2 and its associated glycans — triggers an influx of calcium into the sperm head and the acrosomal reaction: the outer acrosomal membrane fuses with the overlying plasma membrane at multiple points, and the acrosome's contents are released by exocytosis.

Those contents include acrosin, a trypsin-like protease, along with hyaluronidase and other hydrolases. They digest a narrow channel through the zona pellucida directly ahead of the sperm, which the hyperactivated tail then drives it through. The whole passage takes about 15 minutes.

Note the logic: the reaction is triggered by the barrier it is designed to breach, at the exact moment of contact and not before. A sperm that reacts early loses its acrosome, cannot digest the zona, and is finished.

Once through, the sperm reaches the perivitelline space and lies against the oocyte membrane. Fusion is receptor-mediated: IZUMO1, a protein on the sperm's equatorial segment, binds JUNO on the oocyte surface. The two plasma membranes fuse, and the sperm nucleus, its centriole, and its mitochondria enter the oocyte cytoplasm. (Paternal mitochondria are subsequently tagged with ubiquitin and destroyed — which is why mitochondrial DNA is inherited exclusively from the mother, a fact Chapter 29 will use.)

The blocks to polyspermy

If two sperm enter, the resulting cell has 69 chromosomes — triploidy. Triploid conceptions account for perhaps 1–2% of clinically recognized pregnancies and roughly 10% of spontaneous abortions with abnormal karyotype; nearly all are lost, and a paternally derived triploidy typically produces a partial hydatidiform mole. Preventing polyspermy is therefore not a refinement. It is a requirement.

Two mechanisms operate on different timescales.

The fast block is electrical. Within one to three seconds of sperm–oocyte fusion the oocyte membrane depolarizes from about −70 mV toward positive values, and a depolarized membrane does not support further sperm fusion. This mechanism is beautifully characterized in sea urchins; in mammals, including humans, the evidence for a robust fast electrical block is weaker, and the honest statement is that the slow block does most of the work in our species. It is worth knowing the classic account and knowing its limits.

The slow block is chemical and structural, and it is decisive. Sperm entry delivers phospholipase C-zeta (PLCζ) into the oocyte, which generates inositol trisphosphate and triggers a wave of calcium release from the oocyte's endoplasmic reticulum that sweeps across the cell and then repeats as oscillations lasting hours. The first wave triggers the cortical reaction: thousands of cortical granules lying just beneath the oocyte membrane fuse with it and dump their contents into the perivitelline space. The enzyme ovastacin cleaves ZP2, and the zona pellucida hardens and loses its sperm-binding capacity entirely. This is the zona reaction, and it is complete within about a minute.

Predict This

In intracytoplasmic sperm injection (ICSI), an embryologist selects a single sperm and injects it directly through the zona pellucida into the oocyte cytoplasm with a glass needle. Both the acrosomal reaction and the zona reaction are bypassed entirely.

Before reading on: which step of normal fertilization must still occur for the oocyte to develop, and what does that predict about why some ICSI cycles fail even with a morphologically perfect sperm?

(Answer: oocyte activation — the calcium oscillations driven by sperm-derived PLCζ. Without them the oocyte never completes meiosis II and never begins cleavage, no matter how healthy the sperm looks. Mutations in the PLCZ1 gene are a recognized cause of total fertilization failure after ICSI, and such cycles can sometimes be rescued with an artificial calcium ionophore. Structure predicts function even at the level of a single enzyme.)

Completing meiosis II, and the zygote

The oocyte has been sitting in metaphase of meiosis II since ovulation, arrested there by a cytoplasmic activity historically called cytostatic factor. The calcium oscillations release that arrest. The oocyte completes meiosis II and extrudes the second polar body — a tiny cell containing a haploid set of chromosomes and almost no cytoplasm, whose entire function is to discard chromosomes without discarding the cytoplasmic dowry the embryo needs.

What remains is an ootid with a haploid maternal chromosome set. The maternal chromosomes decondense into the female pronucleus; the sperm's tightly packed chromatin exchanges its protamines for histones and swells into the male pronucleus. The two pronuclei migrate toward each other over about 12 hours, their membranes break down, and the chromosomes align on a single mitotic spindle. This is syngamy, and the cell it produces is the zygote: one cell, 46 chromosomes, a complete and unique human genome.

There is a subtlety worth noting because it recurs in genetics. A single diploid nucleus never actually forms at fertilization. The pronuclei dissolve and the two haploid sets meet for the first time on the spindle of the first mitosis. The zygote's two daughter cells are the first cells to possess a true diploid nucleus.

   FERTILIZATION AND THE FIRST WEEK — plotted along the uterine tube
   (hours/days measured from ovulation; not to scale)

   OVARY                    AMPULLA              ISTHMUS         UTERUS
     │                         │                    │               │
   ╭─┴─╮   0 h              ╭──┴──╮              ╭──┴──╮         ╭───┴────╮
   │ ◉ │  OVULATION         │     │              │     │         │        │
   ╰───╯  secondary          │     │              │     │         │        │
     │    oocyte, MII        │     │              │     │         │        │
     │    arrested           │     │              │     │         │        │
     ▼                       ▼                    ▼               ▼
  ┌────────────────────────────────────────────────────────────────────────┐
  │                                                                        │
  │  0 h    ovulation; oocyte swept into fimbriae by ciliary current        │
  │                                                                        │
  │  0–6 h  SPERM ARRIVE. Capacitation (6–8 h in the tract) completes.      │
  │         Hyperactivated motility begins.                                 │
  │                                                                        │
  │  ~12 h  CORONA RADIATA penetrated  (hyaluronidase + mechanical force)   │
  │           │                                                             │
  │           ▼                                                             │
  │         ACROSOMAL REACTION on contact with ZONA PELLUCIDA               │
  │           acrosin digests a channel  ────►  sperm crosses zona ~15 min  │
  │           │                                                             │
  │           ▼                                                             │
  │         MEMBRANE FUSION   IZUMO1 (sperm) ── binds ── JUNO (oocyte)      │
  │           │                                                             │
  │           ├─► FAST BLOCK: membrane depolarises  (seconds; weak in       │
  │           │              humans)                                        │
  │           ├─► Ca²⁺ WAVE from PLCζ ─► CORTICAL REACTION ─► ZONA          │
  │           │              REACTION: ZP2 cleaved, zona hardens (~1 min)   │
  │           │              = SLOW BLOCK, the decisive one                  │
  │           └─► MEIOSIS II COMPLETED ─► 2nd polar body extruded           │
  │                                                                        │
  │  ~18 h  two PRONUCLEI visible                                          │
  │  ~24 h  SYNGAMY ─────────────────►  ZYGOTE (2n = 46)                   │
  │                                                                        │
  │  30 h   2 cells  ─┐                                                     │
  │  40 h   4 cells   │  CLEAVAGE: divisions without growth.                │
  │  3 d    8–16 cells│  Total mass unchanged; cells get smaller.           │
  │         = MORULA ─┘  Compaction at the 8–16 cell stage.                 │
  │                                    ▼ enters UTERINE CAVITY day 3–4      │
  │  4–5 d  BLASTOCYST forms: Na⁺/K⁺-ATPase pumps Na⁺ inward, water         │
  │         follows osmotically, blastocoel cavity opens                     │
  │  5–6 d  HATCHING from the zona pellucida                                │
  │  6–7 d  IMPLANTATION begins in the posterior upper uterine wall          │
  │  8 d    syncytiotrophoblast secreting hCG into maternal blood            │
  │                                                                        │
  └────────────────────────────────────────────────────────────────────────┘

   NOTE: the conceptus must NOT reach the uterus too early. The zona keeps it
   from adhering to the tube; the tube keeps it from reaching an endometrium
   that is not yet receptive. Timing failure at either end = ECTOPIC pregnancy.

Figure 28.1 — Fertilization and the first week, plotted as a timeline along the uterine tube.

Described: A timeline running left to right from the ovary through the ampulla and isthmus of the uterine tube into the uterine cavity, with elapsed time from ovulation on the left. At zero hours the secondary oocyte, arrested in metaphase of meiosis II, is ovulated and swept into the fimbriae by ciliary currents. Within the first six hours sperm arrive and complete capacitation, which takes six to eight hours in the female tract and produces hyperactivated motility. At about twelve hours a sperm penetrates the corona radiata using surface hyaluronidase and mechanical force, then contacts the zona pellucida, which triggers the acrosomal reaction; acrosin digests a channel and the sperm crosses the zona in roughly fifteen minutes. Membrane fusion follows when sperm IZUMO1 binds oocyte JUNO. Fusion triggers three parallel consequences: a fast electrical block by membrane depolarization within seconds, which is well documented in sea urchins but weak in humans; a calcium wave generated by sperm phospholipase C-zeta that drives the cortical reaction, in which ovastacin cleaves ZP2 and the zona hardens within about a minute, constituting the decisive slow block; and completion of meiosis II with extrusion of the second polar body. Two pronuclei are visible by eighteen hours and syngamy produces the diploid zygote at about twenty-four hours. Cleavage follows — two cells at thirty hours, four at forty hours, eight to sixteen cells forming the morula by day three, with compaction at the eight-to-sixteen-cell stage and no increase in total mass. The conceptus enters the uterine cavity on day three or four. On days four to five a sodium-potassium ATPase pumps sodium inward and water follows osmotically, opening the blastocoel. The blastocyst hatches from the zona pellucida on days five to six, implantation in the posterior upper uterine wall begins on days six to seven, and by day eight the syncytiotrophoblast is secreting human chorionic gonadotropin into maternal blood. A closing note observes that the conceptus must not reach the uterus too early: the zona prevents adhesion to the tube and the tube's transit time prevents arrival at an endometrium that is not yet receptive, and failure of timing at either end produces ectopic pregnancy.

Clinical Connection · Ectopic Pregnancy — a Timing Disease

Roughly 1–2% of pregnancies implant somewhere other than the uterine cavity, and about 95% of those are in the uterine tube, most commonly in the ampulla. Ectopic pregnancy remains a leading cause of first-trimester maternal death, and the reason is purely anatomical.

The whole system depends on the conceptus reaching the uterus at day 3–4, hatching at day 5–6, and implanting at day 6–7. Anything that slows tubal transport shifts implantation earlier in the journey — and by the time the blastocyst hatches, an unhatched embryo in the tube becomes a hatched one in the tube, fully competent to invade.

The classic causes are all mechanical or ciliary: prior pelvic inflammatory disease (chlamydial salpingitis destroys the ciliated epithelium and creates adhesions), prior tubal surgery or prior ectopic, endometriosis, and smoking, which impairs ciliary beat frequency and tubal smooth muscle. An intrauterine device prevents intrauterine pregnancy far more effectively than tubal pregnancy, so if a pregnancy occurs with an IUD in place, the probability that it is ectopic is elevated — a conditional risk that is often misreported as the IUD causing ectopics.

The tube is not built to accommodate an invading trophoblast. It has no decidua, a thin muscular wall, and a rich blood supply. Rupture typically occurs at 6–8 weeks and produces massive intraperitoneal hemorrhage. Classic presentation: amenorrhea, unilateral pelvic pain, vaginal bleeding, and — if the diaphragm is irritated by blood — pain referred to the shoulder tip, via the phrenic nerve at C3–C5 (Chapter 13). A serum hCG that fails to roughly double every 48 hours in early pregnancy, with no intrauterine gestational sac visible on transvaginal ultrasound above an hCG of about 1,500–3,500 mIU/mL, is the standard diagnostic pairing.

Check Your Understanding 28.1

  1. Why is it advantageous that hundreds of sperm reach the oocyte when only one can fertilize it?
  2. A researcher blocks the cortical reaction in a mouse oocyte. Fertilization proceeds normally. Predict what happens next and why the embryo will not survive.
  3. Why can a sperm survive five days in the female tract while an oocyte survives only one?
Show answers
  1. Because penetrating the corona radiata is a collective mechanical and enzymatic task. Each sperm carries a small amount of surface hyaluronidase and can exert a small amount of force; the matrix is loosened by the aggregate effort. A single sperm arriving alone at an intact corona is very unlikely to get through. The redundancy is also a filter — the population that survives the vagina, the cervix, and the tubal journey is enriched for normal morphology and motility.
  2. Sperm binding to the zona is not extinguished, so additional sperm cross and fuse: polyspermy. The result is triploidy (69 chromosomes) or worse, plus multiple centrioles producing tripolar or multipolar spindles at the first mitosis. Chromosomes are distributed chaotically, most blastomeres end up aneuploid, and development arrests early. The surviving triploid conceptions are almost all lost in the first trimester.
  3. Because they are doing different jobs. The sperm is a stripped-down delivery vehicle — dense inactive chromatin, minimal cytoplasm, a mitochondrial midpiece for fuel — and it can be held in a quiescent reservoir bound to tubal epithelium and released in waves. The oocyte is a fully loaded cell arrested mid-division, holding a metaphase spindle under tension with its chromosomes unprotected by a nuclear envelope. That state is metabolically expensive and intrinsically unstable; the spindle degrades and the chromosomes scatter within about a day. The asymmetry in survival time is a direct consequence of the asymmetry in structure.

28.2 The First Two Weeks: Cleavage, Blastocyst, and Implantation

The preembryonic period covers weeks 1 and 2. Its business is not building a body. It is building the machinery that will build a body — and, more urgently, establishing a blood supply before the maternal circulation is even aware anything has happened.

Cleavage

The zygote begins dividing about 24–30 hours after fertilization. These early divisions are called cleavage, and they have one defining peculiarity: the cells divide without growing. There is no G1 or G2 phase worth speaking of; the cell cycle is essentially S phase followed by mitosis. The total mass of the conceptus stays roughly constant while the number of cells doubles, so each blastomere is half the size of its parent.

This is not laziness. Until implantation there is no nutrient supply beyond what is in the uterine tube and the oocyte's own cytoplasm, and the oocyte's enormous cytoplasm-to-nucleus ratio must be brought down to something a normal cell can manage. Cleavage does exactly that.

At the 8–16 cell stage the loosely packed ball undergoes compaction: the outer cells flatten against one another, form tight junctions, and become polarized, with an apical surface facing outward. This is the first time cells in a human embryo are visibly different from one another, and the difference is entirely positional. On day 3, a morula — 16 or so cells, from the Latin for mulberry — enters the uterine cavity.

The blastocyst

By day 4–5 the outer cells are pumping. A Na⁺/K⁺-ATPase on their basolateral membranes moves sodium into the interior of the ball; water follows osmotically through aquaporins; and a fluid-filled cavity, the blastocoel, opens up. The structure is now a blastocyst, with two utterly different populations of cells:

  • The trophoblast — the outer single-cell layer surrounding the cavity. It will become the fetal portion of the placenta and the chorion. It contributes nothing to the baby's body.
  • The inner cell mass (embryoblast) — a cluster of 8–30 cells at one pole. It will become the entire embryo, plus the amnion, yolk sac, and allantois.

Roughly 99% of the cells present on day 5 are trophoblast. The overwhelming majority of the early conceptus is not the baby; it is the baby's life support.

          THE BLASTOCYST'S CELL FATES — who becomes what

   DAY 5 BLASTOCYST (~100–150 cells)
   ╭────────────────────────────────────────────────────╮
   │  ○○○○○○○○○○○○○○○○○○○○○○○○  ← TROPHOBLAST          │
   │ ○                        ○    (outer, ~99% of cells)│
   │○   ▓▓▓▓▓▓                 ○                         │
   │○   ▓▓▓▓▓▓ ← INNER CELL    ○   BLASTOCOEL            │
   │○   ▓▓▓▓▓▓    MASS         ○   (fluid-filled)        │
   │ ○   (embryoblast)        ○                          │
   │  ○○○○○○○○○○○○○○○○○○○○○○○○                           │
   ╰────────────────────────────────────────────────────╯
            │                              │
            │                              │
   ┌────────┴─────────┐          ┌─────────┴──────────────┐
   │ INNER CELL MASS  │          │     TROPHOBLAST         │
   └────────┬─────────┘          └─────────┬──────────────┘
            │                              │
   ┌────────┴────────┐          ┌──────────┴───────────┐
   │                 │          │                      │
 EPIBLAST        HYPOBLAST   CYTOTROPHOBLAST     SYNCYTIOTROPHOBLAST
 (dorsal)        (ventral)   (inner, mitotic,    (outer, multinucleate,
   │                 │        stem layer)         NO cell borders)
   │                 │             │                      │
   │                 │             │                      ├─ invades
   ├─ ECTODERM       ├─ yolk sac   ├─ chorionic villus     │  endometrium
   ├─ MESODERM       │  lining     │  cores                ├─ secretes hCG
   ├─ ENDODERM       │             ├─ extravillous         ├─ hormone factory:
   │  ▲              └─ extra-     │  trophoblast that     │  progesterone,
   │  │                embryonic   │  remodels SPIRAL      │  estrogen, hPL
   │  │  ALL THREE     mesoderm    │  ARTERIES             ├─ the actual
   │  │  GERM LAYERS   (part)      │                       │  EXCHANGE
   │  │  COME FROM                 └─ replenishes the      │  SURFACE
   │  │  EPIBLAST                     syncytium            │
   │  │                                                    │
   ├─ AMNION lining                                        │
   └─ PRIMORDIAL GERM CELLS (arise in yolk sac wall,        │
      migrate to the gonadal ridge — Ch. 27)                │
                                                            │
   ═══════════════════════════════════════════════════════════════════
   THE PUNCHLINE: on day 5 about 99% of the cells present will be
   DISCARDED at birth. The baby is built from the ~1% in the epiblast.
   ═══════════════════════════════════════════════════════════════════

Figure 28.2 — Cell fates in the day-5 blastocyst.

Described: A day-five blastocyst of roughly one hundred to one hundred fifty cells is drawn as a sphere with a fluid-filled blastocoel, an outer single layer of trophoblast making up about ninety-nine percent of the cells, and a cluster of inner cell mass cells at one pole. A branching diagram traces the two lineages. The inner cell mass divides into epiblast on the dorsal side and hypoblast on the ventral side. The epiblast gives rise to all three germ layers — ectoderm, mesoderm, and endoderm — and therefore to the entire embryo, and also to the lining of the amnion; the primordial germ cells arise in the wall of the yolk sac and migrate to the gonadal ridge. The hypoblast gives rise to the lining of the yolk sac and contributes to extraembryonic mesoderm. The trophoblast divides into cytotrophoblast and syncytiotrophoblast. The cytotrophoblast is the inner, mitotically active stem layer that forms the cores of the chorionic villi, generates the extravillous trophoblast that remodels the maternal spiral arteries, and continuously replenishes the syncytium. The syncytiotrophoblast is the outer, multinucleate layer with no internal cell borders; it invades the endometrium, secretes human chorionic gonadotropin, functions as the hormone factory producing progesterone, estrogens, and human placental lactogen, and constitutes the actual maternal–fetal exchange surface. The diagram closes with the observation that about ninety-nine percent of the cells present on day five will be discarded at birth, and that the baby is built from the roughly one percent in the epiblast.

Implantation

Around day 5–6 the blastocyst hatches — it digests and squeezes out of the zona pellucida, which has until now kept it from sticking to anything. Free at last, it attaches to the endometrium, usually on the posterior wall of the upper uterine body.

Implantation proceeds in three phases:

  1. Apposition. The blastocyst orients with its inner cell mass facing the endometrium and settles onto the epithelium. The endometrium is receptive only during the window of implantation, days 20–24 of a 28-day cycle (about 6–10 days after ovulation), when progesterone has driven the surface epithelium to develop pinopodes — bleb-like protrusions that absorb uterine fluid and pull the blastocyst against the surface.
  2. Adhesion. L-selectin on the trophoblast binds carbohydrate ligands on the epithelium — the same rolling-adhesion chemistry leukocytes use to stick to blood vessels (Chapter 20) — followed by firm integrin binding.
  3. Invasion. The trophoblast over the point of contact fuses into a multinucleate mass, the syncytiotrophoblast, which secretes proteases and burrows between and through the endometrial epithelial cells. By day 9–10 the entire conceptus is buried within the endometrial stroma and the surface epithelium has grown back over it.

The syncytiotrophoblast deserves a moment. It is a true syncytium — thousands of nuclei in a single continuous cytoplasm with no lateral cell membranes anywhere. There is a reason for this architecture, and it is one of the best structure–function arguments in the book: a continuous sheet with no cell junctions has no paracellular pathway. Nothing can leak between cells because there are no cells to leak between. Every molecule crossing from mother to fetus must cross a membrane, and therefore must be permitted. The placenta's selectivity is built into its cytology.

Thread 1 · Structure Determines Function

The placenta is built out of two structural decisions, and each one is a physical statement about a job.

No cell borders. The syncytiotrophoblast is a single continuous cytoplasm, so there is no route between cells. Everything that crosses must be transported through a membrane, and therefore must be permitted by a transporter, a channel, or sheer lipid solubility. A tissue whose job is selective exchange has been built so that non-selective leak is anatomically impossible.

No smooth muscle. Invading trophoblast destroys the muscular wall of the maternal spiral arteries. A vessel without smooth muscle cannot constrict — which means uteroplacental flow cannot be shut down by a sympathetic surge, a catecholamine release, or a hard run. The placenta secures its blood supply by removing the maternal circulation's ability to withdraw it.

Look at either structure and you can read the requirement off it. When you meet preeclampsia in §28.9, you will find that the disease is precisely the failure of the second decision.

By day 8, the syncytiotrophoblast is secreting human chorionic gonadotropin (hCG) into the maternal blood. This is the signal that rescues the corpus luteum from its programmed regression (§27.7), maintaining progesterone secretion and preventing menstruation. It is also what a home pregnancy test detects, typically from about the time of the missed period.

The bilaminar disc, amnion, and yolk sac

While the trophoblast is invading, the inner cell mass is organizing.

By day 8 it has split into two epithelial sheets stacked face to face — the bilaminar embryonic disc:

  • Epiblast, the dorsal layer of tall columnar cells. Everything in the body comes from here.
  • Hypoblast, the ventral layer of small cuboidal cells. It contributes to extraembryonic structures and, critically, sets up the signals that tell the epiblast where the head end is.

A cavity opens within the epiblast and becomes the amniotic cavity, roofed by the amnion. Hypoblast cells migrate around the inside of the blastocoel to line it, forming the primary yolk sac, which is later remodeled into a smaller secondary yolk sac.

The result is an elegant and slightly odd arrangement: a flat two-layered disc suspended between two balloons — amniotic cavity above, yolk sac below. The disc is the embryo. The balloons are the reason the embryo can grow into a three-dimensional body, because the folding that produces that body is essentially the disc wrapping itself around the yolk sac, inside the expanding amnion.

The yolk sac contains no yolk in humans and provides essentially no nutrition, but it is far from vestigial. It produces the first blood cells and blood vessels (weeks 3–6, before the liver takes over), it hosts the primordial germ cells which migrate from its wall to the gonadal ridge (§27.2), and its dorsal part is incorporated into the embryo as the primitive gut.

The amnion, meanwhile, fills with amniotic fluid: about 30 mL at 10 weeks, 200 mL at 16 weeks, peaking near 800–1,000 mL at 34 weeks and declining thereafter. Early on it is essentially a filtrate of maternal plasma; after about 16 weeks it is overwhelmingly fetal urine, swallowed by the fetus, absorbed across the fetal gut, returned to the fetal circulation and excreted again. The entire volume turns over roughly every three hours. The fluid cushions, permits symmetrical growth, allows limb movement, maintains temperature, and prevents the amnion from adhering to the fetus.

That circuit makes amniotic fluid volume a superb readout of fetal physiology. Oligohydramnios — too little — points to a fetus that is not making urine (renal agenesis, obstruction) or not perfusing its kidneys (placental insufficiency), or to ruptured membranes. Polyhydramnios — too much — points to a fetus that cannot swallow (esophageal atresia, anencephaly, neuromuscular disease) or that is producing excessive urine (maternal diabetes, where fetal hyperglycemia causes an osmotic diuresis). A single number on an ultrasound report constrains the differential diagnosis dramatically.

Histology · The Endometrium Becomes the Decidua

Take a biopsy of secretory endometrium in a non-pregnant cycle and you see coiled glands and loose, spindly stromal cells. Take one at six weeks of pregnancy and the stroma is unrecognizable.

Under sustained progesterone plus signals from the implanting conceptus, endometrial stromal fibroblasts undergo decidualization. They transform from small spindle cells into large, round, pale, epithelioid decidual cells with abundant glycogen and lipid, vesicular nuclei, and a dense pericellular matrix of laminin, fibronectin, and type IV collagen. Under the microscope they look like sheets of plump polygonal cells with clear cytoplasm — closer to an epithelium than to the connective tissue they came from.

Three jobs follow from that appearance:

  • Nutrition. The stored glycogen and lipid feed the conceptus during the first weeks, before placental circulation is established. This is histiotrophic nutrition.
  • Containment. The dense pericellular matrix and the decidual cells' secretion of tissue inhibitors of metalloproteinases (TIMPs) put a brake on trophoblast invasion. Trophoblast is frankly invasive tissue — biologically it behaves much like a tumor — and the decidua is what stops it at the right depth. Where decidua is absent or deficient, as over a uterine scar, invasion does not stop: this is the placenta accreta spectrum, and it is why the rising cesarean rate has produced a rising rate of catastrophic obstetric hemorrhage.
  • Immune modulation. The decidua hosts a distinctive leukocyte population — up to 70% of its lymphocytes are uterine natural killer cells, which despite the name are poorly cytotoxic and instead secrete angiogenic factors that help remodel spiral arteries.

Three named regions, defined by position relative to the conceptus: decidua basalis deep to it (this becomes the maternal side of the placenta), decidua capsularis covering it toward the uterine lumen, and decidua parietalis lining the rest of the cavity. By about week 20 the growing sac obliterates the uterine cavity and capsularis and parietalis fuse.

Twinning

About 3.2% of live births in the United States are twins. The two mechanisms are completely different and have completely different consequences.

Dizygotic (fraternal) twins arise from two oocytes fertilized by two sperm. They are ordinary siblings who happen to share a uterus, sharing on average 50% of their genomes. They always have two placentas and two amnions (dichorionic, diamniotic), although adjacent placentas may fuse and look like one. Dizygotic twinning is heritable through the mother (polyovulation), rises steeply with maternal age and parity, varies several-fold between populations, and has increased dramatically with ovulation induction and IVF.

Monozygotic (identical) twins arise when a single conceptus splits. The rate is remarkably constant — about 3.5 per 1,000 births — across every population studied, and is largely independent of maternal age. Their genomes are essentially identical (though somatic mutations and, importantly, epigenetic differences accumulate — Chapter 29).

What matters clinically is when the split occurs, because it determines what the twins share:

Day of splitting What has already formed Result Frequency of MZ twins
Days 1–3 (morula) Nothing is committed Dichorionic, diamniotic — two placentas, two sacs ~25–30%
Days 4–8 (blastocyst; trophoblast committed, amnion not yet) Trophoblast Monochorionic, diamniotic — one placenta, two sacs ~70%
Days 8–13 (amnion formed) Trophoblast and amnion Monochorionic, monoamniotic — one placenta, one sac ~1–2%
After day 13 (primitive streak formed) The body axis Conjoined twins ~1 in 200 MZ pairs

Read that table as a direct application of Figure 28.2. The twins share whatever had already been made when the split happened. If the trophoblast was already a single unit, they share a placenta forever.

Sharing a placenta is dangerous. Monochorionic twins have vascular anastomoses connecting their circulations, and in 10–15% of them the net flow becomes unbalanced: twin-to-twin transfusion syndrome, in which one twin becomes hypovolemic, anemic, and oliguric with oligohydramnios while the other becomes hypervolemic, polycythemic, polyuric, and develops polyhydramnios and high-output cardiac failure. Determining chorionicity by ultrasound in the first trimester — when the membrane thickness and the "lambda" versus "T" sign at the membrane insertion are still readable — therefore changes surveillance for the entire pregnancy.

Check Your Understanding 28.2

  1. Why does cleavage occur without cell growth, and what would go wrong if the blastomeres grew back to full size between divisions?
  2. A monozygotic twin pair is found on ultrasound to share one placenta and one amniotic sac. Between which days did the split occur, and why is this pregnancy monitored intensively?
  3. An ultrasound at 32 weeks shows severe oligohydramnios. List three mechanistically distinct explanations.
Show answers
  1. Because the conceptus has no external nutrient supply until implantation on day 6–7 — everything it uses is what the oocyte packed — and because the oocyte's cytoplasm-to-nucleus ratio is far too high for normal cell function. Cleavage subdivides that cytoplasm without consuming resources. If the blastomeres grew back to full size, the conceptus would balloon in volume, would exhaust its reserves long before implantation, and could not fit through the isthmus of the uterine tube or hatch from the zona.
  2. Between days 8 and 13 — after the amnion had formed but before the primitive streak. Monoamniotic twins share a single sac with no membrane between them, so cord entanglement is nearly universal and is a major cause of fetal death; they are also monochorionic and so carry the full risk of twin-to-twin transfusion. These pregnancies are usually monitored with frequent surveillance and delivered preterm by cesarean.
  3. (a) The fetus is not making urine — bilateral renal agenesis or severe dysplasia, or posterior urethral valves obstructing outflow. (b) The fetus is not perfusing its kidneys adequately — placental insufficiency causes redistribution of fetal cardiac output toward brain and heart and away from kidneys and gut, so urine output falls; this is the common cause in growth-restricted fetuses and would be highly relevant in a preeclamptic pregnancy. (c) The fluid is leaking out — preterm prelabor rupture of membranes. A fourth: severe maternal dehydration or certain drugs (NSAIDs constrict the fetal ductus and reduce fetal urine output; ACE inhibitors are notorious for fetal anuria).

28.3 The Placenta

By the end of the second week the conceptus has a problem it cannot solve by diffusion. It is buried in endometrium, growing exponentially, and the distance from its center to the nearest maternal capillary already exceeds the roughly 100 micrometers over which diffusion can sustain living tissue (§1.3). It needs a circulation, and it needs one built out of nothing, fast.

The placenta is the answer: an organ assembled jointly by two genetically distinct individuals, functional by week 5, fully in charge of hormone production by week 10, and disposable at week 40.

Building it: villi and decidua

The trophoblast builds the fetal half in three steps, each adding a layer to a branching tree:

  • Primary villi (day 13): finger-like projections of cytotrophoblast pushing into the syncytiotrophoblast.
  • Secondary villi (day 16): extraembryonic mesoderm invades the core.
  • Tertiary villi (day 21): blood vessels differentiate within that mesodermal core and connect to the embryo's own developing circulation. The moment fetal blood begins to circulate through tertiary villi — around day 21, the same week the heart starts beating — the placenta is functional.

Meanwhile the syncytiotrophoblast has been hollowing out lacunae that fill with maternal blood from eroded endometrial vessels (days 11–13). These lacunae coalesce into the intervillous space, and the villous tree grows into it. Villi facing the deep decidua basalis proliferate luxuriantly into the chorion frondosum — the definitive placenta. Villi facing the uterine cavity are compressed, lose their blood supply, and regress into the smooth chorion laeve, which becomes the membrane sac.

At term the placenta is a disc about 22 cm across, 2.5 cm thick, and 470–600 g — roughly a sixth of the baby's weight. Its maternal surface is divided by decidual septa into 15–20 cotyledons. Its villous surface area is 12–14 m², comparable to the absorptive surface of the small intestine, folded into an organ the size of a dinner plate. Uteroplacental blood flow rises from about 50 mL/min in early pregnancy to 500–800 mL/min at term, which is roughly 10–17% of maternal cardiac output.

The exchange interface: two circulations that never meet

This is the single most important structural fact in the chapter, and it is the one students most often get wrong. Maternal and fetal blood do not mix. They are separated by a barrier that in the third trimester is about 2 micrometers thick.

   THE MATERNAL–FETAL EXCHANGE INTERFACE (one terminal villus, term)

   MATERNAL SIDE                                        FETAL SIDE
   ─────────────                                        ──────────
                                       ╭──────────────────────────────╮
   SPIRAL ARTERY                       │  TERMINAL CHORIONIC VILLUS   │
   (remodelled: wide,                  │                              │
    flaccid, low-resistance,           │   ┌────────────────────┐     │
    CANNOT constrict)                  │   │ SYNCYTIOTROPHOBLAST│     │
      ║  ~500–800 mL/min               │   │ multinucleate, NO  │     │
      ║  spurts at ~60–70 mm Hg        │   │ cell borders →     │     │
      ▼                                │   │ NO paracellular    │     │
   ╔═══════════════════════════════╗   │   │ leak. Microvilli   │     │
   ║   INTERVILLOUS SPACE          ║   │   │ face maternal      │     │
   ║   ~150 mL maternal blood      ║───┼──►│ blood.             │     │
   ║   replaced 3–4× per minute    ║   │   ├────────────────────┤     │
   ║   PO₂ ~40–50 mm Hg            ║   │   │ CYTOTROPHOBLAST    │     │
   ║   O₂ sat ~90–98% arterial     ║   │   │ (thins & becomes   │     │
   ║   → ~65–75% venous            ║   │   │  discontinuous     │     │
   ╚═══════════════════════════════╝   │   │  after ~20 wk)     │     │
      ▲                                │   ├────────────────────┤     │
      ║                                │   │ BASEMENT MEMBRANE  │     │
   ENDOMETRIAL VEIN                    │   ├────────────────────┤     │
                                       │   │ VILLOUS STROMA     │     │
   ── THE BARRIER, TOTAL ──            │   │ + Hofbauer cells   │     │
   early:  ~0.025 mm                   │   ├────────────────────┤     │
   term:   ~0.002 mm (2 µm)            │   │ FETAL CAPILLARY    │     │
   surface area at term: 12–14 m²      │   │ ENDOTHELIUM        │     │
                                       │   └─────────┬──────────┘     │
   BLOOD NEVER MIXES.                  │             │                │
   Two circulations, one wall.         │      FETAL CAPILLARY         │
                                       │      PO₂ ~30–35 mm Hg        │
                                       │      sat ~80% (HbF!)         │
                                       ╰──────────────┬───────────────╯
                                                      │
     UMBILICAL ARTERIES ×2  ◄── deoxygenated, sat ~58%, AWAY from fetal heart
     UMBILICAL VEIN   ×1    ──► oxygenated,   sat ~80%, TOWARD fetal heart

   WHAT CROSSES, AND HOW
   ─────────────────────────────────────────────────────────────────────────
   simple diffusion ......... O₂, CO₂, water, urea, most drugs, alcohol,
                              steroid hormones, fatty acids (slowly)
   facilitated diffusion .... GLUCOSE (GLUT1) — never against gradient
   active transport ......... amino acids, calcium, iron, iodine, vitamins
                              (fetal levels EXCEED maternal — uphill)
   receptor-mediated ........ IgG via FcRn (from wk 16, mostly 3rd trimester)
   does NOT cross ........... IgM, heparin, insulin, most large proteins,
                              maternal red and white blood cells (normally)

Figure 28.3 — The maternal–fetal exchange interface at a terminal chorionic villus.

Described: A single terminal chorionic villus is shown suspended in the intervillous space at term. On the maternal side, a remodeled spiral artery — wide, flaccid, low-resistance, and unable to constrict — delivers 500 to 800 millilitres per minute of blood in spurts at about 60 to 70 millimetres of mercury into the intervillous space, which holds roughly 150 millilitres of maternal blood replaced three to four times per minute at an oxygen tension of 40 to 50 millimetres of mercury, with saturation falling from about 90 to 98 percent on the arterial side to 65 to 75 percent on the venous side before draining into endometrial veins. On the fetal side the villus is built in layers from outside in: syncytiotrophoblast, which is multinucleate with no cell borders and therefore offers no paracellular leak, its microvilli facing maternal blood; cytotrophoblast, which thins and becomes discontinuous after about twenty weeks; a basement membrane; villous stroma containing Hofbauer macrophages; and finally fetal capillary endothelium. Fetal capillary blood has an oxygen tension of only 30 to 35 millimetres of mercury yet a saturation near 80 percent because of fetal hemoglobin. The total barrier thickness falls from about 0.025 millimetres early in pregnancy to about 0.002 millimetres, or two micrometres, at term, across a surface area of 12 to 14 square metres. Maternal and fetal blood never mix. Two umbilical arteries carry deoxygenated blood at about 58 percent saturation away from the fetal heart, and one umbilical vein carries oxygenated blood at about 80 percent saturation toward it. A table of transport routes lists simple diffusion for oxygen, carbon dioxide, water, urea, most drugs, alcohol, steroid hormones, and fatty acids; facilitated diffusion by GLUT1 for glucose, which can never move against its gradient; active transport for amino acids, calcium, iron, iodine, and vitamins, so that fetal concentrations exceed maternal ones; receptor-mediated transcytosis by FcRn for immunoglobulin G from about sixteen weeks and mostly in the third trimester; and a final list of substances that do not cross — immunoglobulin M, heparin, insulin, most large proteins, and maternal red and white blood cells under normal conditions.

The four functions

1 · Exchange. Oxygen moves down its gradient — but look at the numbers. Maternal intervillous PO₂ is only 40–50 mm Hg, and fetal umbilical venous PO₂ is 30–35 mm Hg. The fetus lives its entire prenatal life at an oxygen tension a mountaineer would find at the summit of Everest. It compensates with three tricks: a higher hemoglobin concentration (17–18 g/dL, hematocrit 50–55%), a left-shifted oxygen dissociation curve (fetal hemoglobin, α₂γ₂, binds 2,3-BPG poorly; P₅₀ is about 19 mm Hg versus 27 in the adult), and a double Bohr effect — CO₂ moving from fetus to mother simultaneously acidifies maternal blood, which unloads maternal oxygen, and alkalinizes fetal blood, which loads it. The same gradient does double duty.

Glucose crosses by facilitated diffusion via GLUT1 and therefore can never exceed the maternal concentration. Amino acids, in contrast, cross by active transport and fetal concentrations run higher than maternal. Iron is pulled across against a steep gradient by transferrin receptors, which is why a fetus can be iron-replete while its mother is anemic.

2 · Endocrine. The placenta is the largest endocrine organ a human body ever contains.

Hormone Source and timing What it does
hCG Syncytiotrophoblast from day 8; doubles every 48 h; peaks 8–10 wk at ~100,000 mIU/mL, then falls to a plateau Rescues the corpus luteum → maintains progesterone until the luteal–placental shift at 7–9 weeks. Its α subunit is identical to that of LH, FSH, and TSH, so at peak concentrations it cross-stimulates the thyroid — the mechanism of gestational thyrotoxicosis and part of the reason nausea peaks when hCG does
Progesterone Syncytiotrophoblast, from maternal cholesterol; 25 mg/day at 6 wk → 250 mg/day at term Quiets the myometrium, maintains the decidua, suppresses maternal cell-mediated immunity, relaxes smooth muscle everywhere else as a side effect
Estrogens (estriol dominant) The fetoplacental unit — placenta lacks 17α-hydroxylase, so it needs fetal adrenal DHEA-S, 16α-hydroxylated by fetal liver Uterine growth and blood flow, breast duct development, upregulation of oxytocin receptors and gap junctions near term. Because estriol synthesis requires a living fetal adrenal and liver, falling estriol was historically a fetal-wellbeing test
hPL (human placental lactogen) Syncytiotrophoblast; rises with placental mass to ~1 g/day at term Maternal insulin antagonist and lipolytic agent — the principal driver of the deliberate insulin resistance of §28.6
CRH Syncytiotrophoblast; rises exponentially from ~20 wk The "placental clock." Unlike the hypothalamus, placental CRH is stimulated rather than suppressed by cortisol — a positive feedback that helps set the timing of labor

3 · Immune. The fetus expresses paternal antigens and should be rejected as a semi-allograft. It is not, and the placenta is why. The syncytiotrophoblast expresses no classical MHC class I or class II molecules at all, making it invisible to maternal T cells. The invading extravillous trophoblast expresses instead the non-classical molecules HLA-G, HLA-E, and HLA-C, which engage inhibitory receptors on uterine NK cells — this both prevents killing and recruits those NK cells to help remodel spiral arteries. The decidua accumulates regulatory T cells, tryptophan is locally depleted by indoleamine 2,3-dioxygenase (T cells cannot proliferate without it), and progesterone shifts the local response away from inflammatory Th1 toward Th2. Tolerance is not passive; it is actively manufactured.

4 · Barrier — and what crosses anyway. The placenta stops IgM, heparin, insulin, bacteria, and most large proteins. It does not stop much else. Alcohol crosses freely and equilibrates within minutes; fetal blood alcohol matches maternal, and the fetal liver lacks mature alcohol dehydrogenase. Nicotine and carbon monoxide cross. Nearly all drugs with molecular weight below about 500 daltons and any appreciable lipid solubility cross. Viruses cross — cytomegalovirus, rubella, Zika, parvovirus B19, HIV, syphilis. And IgG is not merely permitted but actively pumped across by neonatal Fc receptors, which is how a newborn arrives with adult-level antibody titers against everything its mother is immune to — and also how anti-D antibodies reach and destroy fetal red cells in Rh disease (§28.9).

"Placental barrier" is a phrase worth retiring. It is a selective interface, and much of its selectivity runs the wrong way for the fetus.

The umbilical cord

The cord is 55–60 cm long and about 2 cm across, containing two umbilical arteries and one umbilical vein wound in a helix within Wharton's jelly — a mucoid connective tissue rich in hyaluronic acid whose turgor resists compression and kinking, and which contains no vasa vasorum and no innervation.

The naming seems backwards, and generations of students have mis-answered exam questions on it. It is not backwards; the definitions are simply not about oxygen.

An artery is a vessel carrying blood AWAY from the heart. A vein carries blood TOWARD the heart. Oxygen content is not part of the definition — it is merely true of most vessels in a postnatal body.

The umbilical arteries branch from the fetal internal iliac arteries and carry deoxygenated blood (saturation ~58%) away from the fetus to the placenta for gas exchange. The umbilical vein returns oxygenated blood (saturation ~80%) toward the fetal heart. This is exactly the same convention that makes the pulmonary artery deoxygenated and the pulmonary veins oxygenated in you, right now. The umbilical vessels are, functionally, the fetus's pulmonary circulation — with the placenta as the lung.

About 1% of cords have a single umbilical artery; roughly 20–30% of those infants have an associated renal or cardiac anomaly, which is why the sonographer counts vessels.

Imaging · Obstetric Ultrasound, Trimester by Trimester

Ultrasound works by timing the echoes of high-frequency sound at tissue interfaces. It cannot cross bone or air, which is a disadvantage almost everywhere in the body and an advantage here: a fetus is suspended in fluid, surrounded by soft tissue, and is essentially the ideal ultrasound subject. No ionizing radiation is involved, so the study can be repeated freely.

First trimester (transvaginal, 6–13 weeks). The probe sits within centimetres of the uterus, so a high frequency (7–10 MHz) can be used and resolution is excellent. A gestational sac is visible at about 4.5–5 weeks, a yolk sac at 5.5, a fetal pole with cardiac activity at 6. The key measurement is the crown–rump length, which between 7 and 13 weeks predicts gestational age to within ±5 days — better than any later measurement and better than a certain last menstrual period, because early growth is almost independent of genetic and nutritional variation. Every date in the pregnancy afterward is anchored to this number.

Nuchal translucency (11–13⁺⁶ weeks). A sagittal image of the fetal neck measures the sonolucent fluid layer beneath the skin, normally under 3 mm. It is increased in trisomy 21, 18, and 13, in Turner syndrome, and in congenital heart disease — in each case because lymphatic development lags, cardiac function is impaired, or extracellular matrix is abnormal, so fluid transiently pools at the nape. Combined with maternal age and the serum markers PAPP-A and free β-hCG, it detects about 85–90% of trisomy 21 at a 5% false-positive rate. It is a screen, not a diagnosis.

Second trimester (18–22 weeks) — the anatomy survey. The fetus is large enough to see and still small enough to fit in the field. Every organ system is examined in a defined sequence, biometry is measured (biparietal diameter, head circumference, abdominal circumference, femur length) and combined into an estimated fetal weight, the placenta is localized (is it covering the cervix? — placenta previa), amniotic fluid is quantified, and the cervical length is measured as a predictor of preterm birth.

Third trimester — growth and wellbeing. Serial biometry tracks growth velocity, which matters more than any single measurement. Amniotic fluid volume, the biophysical profile (tone, movement, breathing movements, fluid), and Doppler studies assess placental function.

Umbilical artery Doppler deserves its own paragraph, because it is the closest thing in clinical medicine to reading placental resistance directly. In a normally developing placenta the villous vascular bed is a huge, low-resistance network, so blood keeps moving forward through the umbilical arteries even during fetal diastole, and the ratio of systolic to diastolic velocity falls steadily across gestation. When villous vessels are obliterated — as in the placental disease of §28.9 — resistance climbs, and diastolic flow falls, then disappears (absent end-diastolic flow), then reverses (reversed end-diastolic flow, meaning blood is briefly flowing backward toward the fetus during diastole). That progression maps onto worsening fetal hypoxia and rising stillbirth risk, and it is often the finding that determines the delivery date. Doppler adds no new anatomy; it measures a mechanism.

Check Your Understanding 28.3

  1. A pregnant woman is given intravenous insulin. Her blood glucose falls. Does the fetal blood glucose fall? Explain using the transport mechanism.
  2. Why does the fetus require a hemoglobin concentration of 17–18 g/dL when an adult manages on 13–15?
  3. Explain to a classmate, in two sentences, why the umbilical artery carries deoxygenated blood.
Show answers
  1. Yes, fetal glucose falls — but not because insulin crossed. Insulin does not cross the placenta. Glucose crosses by facilitated diffusion down its concentration gradient via GLUT1, so fetal glucose passively tracks maternal glucose with a small lag and a slightly lower value. Lower the mother's glucose and you lower the fetus's. This is exactly why maternal insulin therapy is safe and effective in diabetic pregnancy, and also why the fetus of a hyperglycemic mother makes its own insulin in excess — the glucose crosses, the insulin does not, and the fetal pancreas responds to what it sees.
  2. Because it is extracting oxygen from blood at an intervillous PO₂ of only 40–50 mm Hg and delivering it at an umbilical venous PO₂ of 30–35. Oxygen delivery is the product of blood oxygen content and flow, and content is dominated by hemoglobin concentration. With the partial pressure fixed low by placental geometry, the only levers available are more hemoglobin, higher-affinity hemoglobin, and higher flow — and the fetus uses all three.
  3. Vessels are named by the direction they carry blood relative to the heart, not by what is in them: arteries carry blood away, veins carry it toward. The umbilical arteries are carrying the fetus's used, deoxygenated blood away from its heart to the placenta to be refreshed — precisely as your pulmonary arteries carry deoxygenated blood away from your heart to your lungs.

28.4 The Embryonic Period: Weeks 3–8

Weeks 3 through 8 are the most consequential five weeks of a human life. The embryo enters them as a flat two-layered disc about 0.2 mm long and leaves them as a recognizable human being 30 mm long with every organ system present in rudimentary form. It is also, for exactly that reason, the period of maximum vulnerability.

Gastrulation: making three layers from one

On about day 15 a groove appears in the caudal midline of the epiblast: the primitive streak, with a thickening at its cranial end, the primitive node. The streak establishes the embryo's axes — cranial–caudal, left–right, dorsal–ventral — for the first time.

Epiblast cells migrate toward the streak, detach from the epithelium, and slip beneath it in a process called ingression:

  • The first wave displaces the hypoblast entirely and becomes the endoderm.
  • The second wave spreads between the two layers and becomes the mesoderm.
  • Cells remaining in the upper layer become the ectoderm.

Note carefully: all three germ layers derive from the epiblast. The hypoblast is evicted.

Cells passing through the primitive node migrate cranially in the midline to form the notochord, a rod of cells that is the embryo's first skeletal element and, far more importantly, its principal organizing signal. The notochord induces the overlying ectoderm to become nervous tissue and instructs the surrounding mesoderm on how to pattern the vertebrae. In the adult it survives only as the nucleus pulposus at the center of each intervertebral disc.

   THE THREE GERM LAYERS AND WHAT THEY BECOME

   ┌────────────── ECTODERM (outer) ──────────────────────────────────────┐
   │  SURFACE ECTODERM                                                    │
   │    epidermis · hair · nails · sweat & sebaceous glands               │
   │    MAMMARY glands · tooth enamel · lens & cornea epithelium          │
   │    anterior pituitary · inner ear epithelium                         │
   │  NEUROECTODERM (neural tube)                                          │
   │    brain · spinal cord · retina & optic nerve · posterior pituitary   │
   │    pineal gland · motor neurons                                       │
   │  NEURAL CREST  ← the "fourth germ layer"; migrates everywhere         │
   │    sensory & autonomic ganglia · Schwann cells · ADRENAL MEDULLA      │
   │    MELANOCYTES · most of the facial skeleton & branchial cartilages   │
   │    aorticopulmonary septum of the HEART · enteric nervous system      │
   └──────────────────────────────────────────────────────────────────────┘

   ┌────────────── MESODERM (middle) ─────────────────────────────────────┐
   │  PARAXIAL (somites) → sclerotome: vertebrae, ribs                    │
   │                     → myotome:    skeletal muscle                     │
   │                     → dermatome:  dermis of the back                  │
   │  INTERMEDIATE       → kidneys, ureters, gonads, genital ducts         │
   │  LATERAL PLATE                                                        │
   │    somatic  → body wall connective tissue, limb bones, parietal serosa│
   │    splanchnic → HEART, blood vessels, blood, smooth muscle of gut,    │
   │                 visceral serosa, spleen, adrenal CORTEX               │
   └──────────────────────────────────────────────────────────────────────┘

   ┌────────────── ENDODERM (inner) ──────────────────────────────────────┐
   │  EPITHELIAL LINING of the gut tube, from pharynx to upper anal canal  │
   │  + everything that buds off it:                                       │
   │    LIVER · pancreas · gallbladder                                     │
   │    LUNGS & respiratory epithelium (a ventral bud off the foregut)     │
   │    THYROID · parathyroids · thymus (pharyngeal pouches)               │
   │    epithelium of bladder & urethra · tonsils · auditory tube          │
   └──────────────────────────────────────────────────────────────────────┘

   THE RULE OF THUMB THAT ACTUALLY WORKS
   ─────────────────────────────────────────────────────────────────────────
   ECTODERM  = what touches the OUTSIDE WORLD or PROCESSES it
               (skin, nervous system, sense organs)
   MESODERM  = what MOVES, SUPPORTS, or CIRCULATES
               (muscle, bone, blood, heart, kidney, gonad)
   ENDODERM  = the LINING of tubes and the glands that bud from them
               (gut and lung epithelium, liver, pancreas, thyroid)

   WATCH THE EXCEPTIONS: adrenal CORTEX is mesoderm but adrenal MEDULLA is
   neural crest — two germ layers in one gland, which is why they secrete
   completely unrelated hormones (Ch. 16).

Figure 28.4 — The three germ layers and their principal derivatives.

Described: Three boxes list the derivatives of each germ layer. Ectoderm, the outer layer, is divided into three parts. Surface ectoderm gives rise to the epidermis, hair, nails, sweat and sebaceous glands, mammary glands, tooth enamel, the epithelium of the lens and cornea, the anterior pituitary, and inner ear epithelium. Neuroectoderm, derived from the neural tube, gives rise to the brain, spinal cord, retina and optic nerve, posterior pituitary, pineal gland, and motor neurons. Neural crest, sometimes called the fourth germ layer because it migrates throughout the body, gives rise to sensory and autonomic ganglia, Schwann cells, the adrenal medulla, melanocytes, most of the facial skeleton and branchial cartilages, the aorticopulmonary septum of the heart, and the enteric nervous system. Mesoderm, the middle layer, is divided into paraxial mesoderm, which forms somites that yield sclerotome for vertebrae and ribs, myotome for skeletal muscle, and dermatome for the dermis of the back; intermediate mesoderm, which forms kidneys, ureters, gonads, and genital ducts; and lateral plate mesoderm, whose somatic division forms body wall connective tissue, limb bones, and parietal serosa, and whose splanchnic division forms the heart, blood vessels, blood, gut smooth muscle, visceral serosa, spleen, and adrenal cortex. Endoderm, the inner layer, forms the epithelial lining of the gut tube from pharynx to upper anal canal and everything budding from it: liver, pancreas, gallbladder, lungs and respiratory epithelium, thyroid, parathyroids, thymus, the epithelium of bladder and urethra, tonsils, and auditory tube. A summary rule follows: ectoderm becomes what touches or processes the outside world, mesoderm becomes what moves, supports, or circulates, and endoderm becomes the lining of tubes and the glands budding from them. A caution notes that the adrenal cortex is mesodermal while the adrenal medulla is neural crest — two germ layers in one gland, which explains why they secrete entirely unrelated hormones.

Neurulation

Days 18–28. The notochord signals the overlying ectoderm to thicken into the neural plate. Its edges rise into neural folds, which curl toward each other and fuse in the midline to form the neural tube, which then sinks beneath the surface ectoderm.

Fusion begins in the future cervical region around day 22 and zips both cranially and caudally like a two-way zipper. The cranial neuropore closes about day 25; the caudal neuropore about day 27–28. The cells at the crest of the folds — the neural crest — detach and migrate throughout the embryo to become an astonishing variety of structures (Figure 28.4).

The whole of neurulation is finished by day 28 — often before a woman knows she is pregnant. That fact drives one of the most successful public health interventions in modern medicine.

Development · Neural Tube Defects and Folate

If the cranial neuropore fails to close by day 25, the forebrain develops in contact with amniotic fluid, degenerates, and the cranial vault never forms: anencephaly, universally lethal. If the caudal neuropore fails by day 28, the result is spina bifida — ranging from occulta (a vertebral arch defect with intact overlying skin, often an incidental finding in perhaps 10% of people) through meningocele to myelomeningocele, in which neural tissue itself herniates and is damaged, producing paralysis and sensory loss below the level, bladder and bowel dysfunction, and — through tethering of the hindbrain — the Chiari II malformation with hydrocephalus in the great majority.

Folate (vitamin B₉) is required for one-carbon transfer reactions: the synthesis of purines and thymidylate, and the remethylation of homocysteine to methionine, which supplies S-adenosylmethionine, the universal methyl donor for DNA and histone methylation (Chapter 29). Neurulating neuroepithelium is among the fastest-dividing tissue in the embryo and is exquisitely dependent on both functions.

Randomized trials in the early 1990s showed that 400 µg/day of periconceptional folic acid reduces neural tube defects by roughly 70%, and that a woman with a previously affected pregnancy needs 4 mg/day. Mandatory folic acid fortification of grain products, adopted in the United States and Canada in 1998 and now in over eighty countries, cut neural tube defect rates by 25–50% within a few years.

The critical detail is timing, and it is pure embryology. Supplementation must begin before conception, because the neuropores close on days 25–28 — roughly eleven to fourteen days after a missed period. A woman who starts folic acid when her pregnancy test turns positive has already missed the window. This is why the recommendation is directed at all people capable of becoming pregnant, not at pregnant people, and it is a case where knowing the developmental timetable changes the entire design of the intervention.

Anticonvulsants that interfere with folate metabolism — valproate above all, which carries a 1–2% neural tube defect risk — matter for the same reason.

Folding

During week 4 the flat disc becomes a cylinder through two simultaneous folds.

Cephalocaudal folding occurs because the neural tube grows much faster than the surrounding tissue and overhangs at both ends, curling the disc into a C shape. This drags the cardiogenic area, which began cranial to the neural plate, backward and downward into what becomes the thorax — which is why the heart ends up below the head and why the phrenic nerve, supplying a diaphragm that also migrates caudally, comes all the way from C3–C5.

Lateral folding brings the two edges of the disc around ventrally to meet in the midline, enclosing the body cavity and rolling the endoderm into a tube — the primitive gut. The connection to the yolk sac narrows into the vitelline duct and normally disappears; when a remnant persists it is a Meckel diverticulum, present in about 2% of people.

Organogenesis and critical periods

By the end of week 8: the heart has been beating since day 22; limb buds appeared at days 26–28 and have hands and feet with separated digits; the face has formed by the fusion of five prominences; the gut has rotated; primary brain vesicles have subdivided; and the embryo has graduated to being called a fetus.

A critical period is the interval during which a given structure is being actively formed and is therefore susceptible to disruption. A teratogen is any agent that can cause a structural or functional birth defect.

   TERATOGEN SUSCEPTIBILITY BY ORGAN SYSTEM AND WEEK
   ███ = maximum sensitivity (major structural defects)
   ░░░ = reduced sensitivity (functional defects, minor anomalies)

   WEEK  1   2 │ 3   4   5   6   7   8 │ 9  12  16  20  24  32  38
        ──────┼───────────────────────┼──────────────────────────
        PRE-  │   EMBRYONIC PERIOD    │      FETAL PERIOD
        EMBRY │   (organogenesis)     │      (growth + maturation)
        ──────┼───────────────────────┼──────────────────────────
   CNS   ▒▒▒▒ │███ ███ ███ ███ ░░░ ░░░│░░░ ░░░ ░░░ ░░░ ░░░ ░░░ ░░░
   HEART ▒▒▒▒ │    ███ ███ ███ ░░░    │
   ARMS  ▒▒▒▒ │        ███ ███ ░░░    │
   LEGS  ▒▒▒▒ │        ███ ███ ░░░    │
   EYES  ▒▒▒▒ │    ███ ███ ███ ███ ░░░│░░░ ░░░ ░░░ ░░░
   TEETH ▒▒▒▒ │            ███ ███ ░░░│░░░
   PALATE▒▒▒▒ │            ███ ███ ░░░│
   EAR   ▒▒▒▒ │    ███ ███ ███ ███ ███│░░░ ░░░
   EXT.  ▒▒▒▒ │                ███ ███│███ ░░░
   GENIT.

   ▒▒▒▒ WEEKS 1–2: "ALL OR NONE."  The pre-implantation conceptus has
        totipotent cells that can replace losses. An insult either kills
        it (unrecognised loss) or is fully repaired. Structural defects
        essentially do not arise here.

   ███ WEEKS 3–8: MAXIMUM RISK. Every organ is being assembled. This is
        when thalidomide (days 20–36) produced phocomelia, and when
        rubella produces the cardiac–ocular–auditory triad.

   ░░░ WEEK 9 ONWARD: organs exist; they now GROW and DIFFERENTIATE.
        Insults cause growth restriction and FUNCTIONAL deficits rather
        than gross malformation — with the CNS and eye still vulnerable
        because they are still building circuits at term and beyond.

   SELECTED TERATOGENS AND THEIR WINDOWS
   ────────────────────────────────────────────────────────────────────
   Alcohol .............. all of gestation; no established safe dose.
                          Facial dysmorphology from wk 3–6; CNS effects
                          throughout, including the third trimester
   Isotretinoin ......... wk 3–5: craniofacial, cardiac, thymic, CNS
   Thalidomide .......... days 20–36 ONLY: limb reduction (phocomelia)
   Warfarin ............. wk 6–9: nasal hypoplasia, stippled epiphyses;
                          later: fetal intracranial haemorrhage
   ACE inhibitors/ARBs .. 2nd–3rd trimester: fetal renal failure,
                          oligohydramnios, skull hypoplasia
   Valproate ............ wk 3–4: neural tube defects (1–2%); throughout:
                          reduced IQ, autism risk
   Tetracycline ......... 2nd trimester onward: tooth staining, enamel
   Rubella .............. wk 1–8: deafness, cataract, PDA, "blueberry
                          muffin" rash. After 20 wk: little risk
   Untreated maternal PKU wk 3–8: microcephaly, cardiac defects,
                          intellectual disability — the teratogen is the
                          MOTHER'S phenylalanine, not a drug

Figure 28.5 — Teratogen susceptibility by organ system and gestational week.

Described: A grid plots gestational weeks 1 through 38 across the top against organ systems down the side, with shading indicating sensitivity. Weeks 1 and 2 are the pre-embryonic period, weeks 3 through 8 the embryonic period of organogenesis, and week 9 onward the fetal period of growth and maturation. Maximum sensitivity to major structural defects, shown as solid shading, occurs for the central nervous system in weeks 3 through 6, the heart in weeks 4 through 7, the arms and legs in weeks 5 through 7, the eyes in weeks 4 through 8, the teeth in weeks 6 through 8, the palate in weeks 6 through 8, the ear in weeks 4 through 9, and the external genitalia in weeks 8 through 12. Reduced sensitivity producing functional defects and minor anomalies extends beyond each of those windows, and for the central nervous system and eye it persists to term. Weeks 1 and 2 are labelled all-or-none: the pre-implantation conceptus still has totipotent cells that can replace losses, so an insult either kills it, often unrecognised, or is fully repaired, and structural defects essentially do not arise. Weeks 3 through 8 carry maximum risk because every organ is being assembled; this is when thalidomide taken on days 20 to 36 produced phocomelia and when rubella produces its cardiac, ocular, and auditory triad. From week 9 onward organs exist and are growing and differentiating, so insults cause growth restriction and functional deficits rather than gross malformation, with the central nervous system and eye remaining vulnerable because they are still building circuits at term. A table of selected teratogens lists alcohol, with no established safe dose and effects throughout gestation; isotretinoin in weeks 3 to 5; thalidomide on days 20 to 36 only; warfarin in weeks 6 to 9; ACE inhibitors and angiotensin receptor blockers in the second and third trimesters; valproate in weeks 3 to 4 and throughout; tetracycline from the second trimester; rubella in weeks 1 to 8; and untreated maternal phenylketonuria in weeks 3 to 8, where the teratogen is the mother's own phenylalanine rather than a drug.

Three principles govern all of this. Timing determines which structure is affected — the same drug on day 22 and day 60 produces entirely different outcomes, or none. Dose matters, and most teratogens have a threshold below which no effect is detectable (alcohol is the uncomfortable exception, with no threshold ever demonstrated). And genotype matters: only some exposed embryos are affected, because susceptibility depends on the metabolic and developmental genes of both mother and embryo — a point Chapter 29 develops.

Development · Cleft Lip and Cleft Palate — Two Defects, Two Timetables

The face is built by the fusion of five swellings around the primitive mouth: one frontonasal prominence, two maxillary prominences, and two mandibular prominences, populated largely by migrating neural crest cells.

Cleft lip results from failure of the maxillary prominence to fuse with the medial nasal prominence on one or both sides. That fusion happens in weeks 6–7. Because the two sides fuse independently, cleft lip may be unilateral (more often on the left) or bilateral, and because the lip and the primary palate anterior to the incisive foramen form together, cleft lip commonly extends into the alveolus.

Cleft palate results from failure of the two palatine shelves to elevate from a vertical position on either side of the tongue to a horizontal position above it, and then fuse in the midline. That happens later — weeks 8–12, and about a week later in females than males, which is why isolated cleft palate is more common in girls while cleft lip with or without cleft palate is more common in boys.

Two lessons follow. First, these are separate embryological events with separate critical windows, which is why "cleft lip and palate" and "isolated cleft palate" have different genetics, different associated syndromes, and different recurrence risks — they are not degrees of one disorder. Second, anything that keeps the tongue from dropping out of the way prevents shelf elevation and causes cleft palate secondarily: in the Pierre Robin sequence, a small mandible holds the tongue high, the shelves cannot elevate, and a U-shaped cleft palate results. One primary defect, a mechanical consequence, and a second defect — the definition of a sequence rather than a syndrome.


28.5 The Fetal Period: Week 9 to Birth

The embryo built the organs. The fetus grows them, matures them, and — crucially — rehearses with them. Fetal weight rises roughly 700-fold between week 9 and term.

Period Crown–rump / weight Milestones
Weeks 9–12 5→9 cm; 8→45 g Ossification centers appear; external genitalia distinguishable by week 12; kidneys begin producing urine; intestines return from the umbilical cord (physiologic herniation resolves by week 11); fetus swallows
Weeks 13–16 9→14 cm; 45→200 g Rapid growth; coordinated limb movement; scalp hair pattern forms; skeletal ossification visible on radiograph; sex readily determined by ultrasound
Weeks 17–20 14→19 cm; 200→460 g Quickening — the mother feels movement; vernix caseosa and lanugo appear; brown adipose tissue deposited; myelination of the spinal cord begins
Weeks 21–24 19→23 cm; 460→820 g Type II pneumocytes begin making surfactant (~week 24); alveolar capillaries approach the airspaces; skin wrinkled and translucent; eyelids reopen. Limit of viability ~22–24 weeks
Weeks 25–28 23→27 cm; 820→1,300 g Substantial surfactant; central nervous system can control rhythmic breathing and body temperature — badly; eyes open; erythropoiesis shifts from spleen to bone marrow
Weeks 29–32 27→30 cm; 1,300→2,100 g Rapid weight gain; subcutaneous white fat accumulates; toenails; the fetus mounts a systemic response to noise and light
Weeks 33–36 30→34 cm; 2,100→2,900 g Surfactant adequate in most by 34–36 weeks; body fills out; lanugo shed; iron and calcium stores laid down
Weeks 37–40 34→36 cm; 2,900→3,400 g Term. Fetal weight roughly doubles in the last eight weeks. Maternal IgG transfer peaks; the fetus descends into the pelvis

Two of those lines carry most of the clinical weight. Surfactant — the phospholipid film that lowers alveolar surface tension and prevents alveolar collapse at end-expiration (Chapter 22) — is the single variable that most determines whether a preterm infant survives without intensive support, and it is the reason antenatal corticosteroids given to the mother between 24 and 34 weeks reduce neonatal death: cortisol is the physiological trigger for surfactant synthesis, and the drug simply anticipates the fetal signal. And the last eight weeks are when the fetus doubles in weight, which is why a baby born at 32 weeks is not merely early but structurally unfinished, with negligible fat, negligible glycogen, and negligible iron reserve.

Fetal circulation: three shunts and a very good reason for each

The fetal cardiovascular system solves a problem no postnatal system faces: the organ of gas exchange is not in the body. Oxygen arrives at the abdomen, by way of the umbilical vein, and the lungs — fluid-filled, collapsed, and vasoconstricted by their own low alveolar oxygen tension — represent a high-resistance dead end that must be bypassed.

Three shunts accomplish the bypass, and the fetal ventricles consequently work in parallel rather than in series. Both ventricles pump into the systemic circulation, and the right ventricle is the dominant one, handling about 55–60% of the combined ventricular output of roughly 450 mL/kg/min.

   FETAL CIRCULATION — three shunts, with O₂ SATURATION at each point

                          PLACENTA  (the "lung")
                              │  sat ~80%, PO₂ 30–35 mm Hg
                    UMBILICAL VEIN (1)  ──── the most oxygenated
                              │              blood in the fetus
                              ▼
                     ┌────────────────┐
                     │     LIVER      │◄─ portal vein (sat ~30%)
                     │                │
                     │  ~50% of flow  │      ★ SHUNT 1 ★
                     │  perfuses      │   DUCTUS VENOSUS
                     │  hepatocytes ──┼──► bypasses the hepatic
                     └────────────────┘    sinusoids; ~50% of
                              │            umbilical flow, at speed
                              ▼            ─────────────────────────
                    INFERIOR VENA CAVA     WHY: the placenta already
                     sat ~67% (mixed)      does the liver's clearing
                              │            and synthesis. Sparing the
                              ▼            best blood from a slow,
                     ┌─────────────────┐   high-extraction organ keeps
   SVC ──sat ~40%──► │  RIGHT ATRIUM   │   it hot for the brain.
                     └────────┬────────┘
                        ┌─────┴─────┐          ★ SHUNT 2 ★
                        │           │       FORAMEN OVALE
   the crista dividens  │           └──────► RA → LA directly.
   STREAMS the IVC      │                    The IVC stream is aimed
   stream across the    ▼                    at it by the Eustachian
   septum; SVC blood   RIGHT VENTRICLE       valve, so OXYGENATED
   is aimed at the      │  sat ~52%          blood crosses while SVC
   tricuspid valve.     ▼                    blood does not.
                    PULMONARY TRUNK          ────────────────────────
                        │                    WHY: fills the LEFT side,
              ┌─────────┴────────┐           which supplies the CORONARY
              │                  │           and CEREBRAL arteries with
        ~10% to LUNGS     ★ SHUNT 3 ★        the fetus's best blood.
        (high PVR:      DUCTUS ARTERIOSUS
         fluid-filled,   ~90% of RV output   ┌─────────────────────┐
         hypoxic         │                   │   LEFT ATRIUM       │
         vasoconstriction)▼                  │        ▼            │
                    DESCENDING AORTA         │   LEFT VENTRICLE    │
                     sat ~58%                │        ▼            │
                        │              ◄─────┤  ASCENDING AORTA    │
                        │                    │  sat ~65% ← HIGHEST │
                        │                    │  after the umbilical│
                        ▼                    │  vein               │
              lower body · UMBILICAL          └──────┬──────────────┘
              ARTERIES (2) ──► placenta              │
                     sat ~58%                   head, neck, arms,
                                                CORONARY arteries
   ══════════════ AT BIRTH: WHAT CHANGES, IN ORDER ═══════════════════════
   1. First breath → lungs inflate, alveolar PO₂ rises → pulmonary
      vasoconstriction released → PVR falls ~10-fold within minutes
   2. Cord clamped → the huge low-resistance placental bed is removed →
      systemic vascular resistance RISES abruptly
   3. Pulmonary venous return floods the LA → LA pressure now EXCEEDS RA
      pressure → septum primum is pressed against septum secundum →
      FORAMEN OVALE closes functionally in minutes (fuses over months;
      stays probe-patent in ~25% of adults = patent foramen ovale)
   4. Arterial PO₂ rises AND placental PGE₂ is gone (the lungs metabolise
      what remains) → DUCTUS ARTERIOSUS constricts over 10–15 h →
      fibroses by 2–3 weeks → LIGAMENTUM ARTERIOSUM
   5. Umbilical flow ceases → DUCTUS VENOSUS closes in 3–7 days →
      LIGAMENTUM VENOSUM
   6. Umbilical vein → LIGAMENTUM TERES (round ligament of the liver)
      Umbilical arteries → MEDIAL UMBILICAL LIGAMENTS
   The ventricles now work IN SERIES. Same plumbing, rewired in a day.

Figure 28.6 — Fetal circulation with the three shunts, oxygen saturations, and the changes at birth.

Described: Blood returns from the placenta in the single umbilical vein at about 80 percent oxygen saturation and an oxygen tension of 30 to 35 millimetres of mercury — the most oxygenated blood in the fetus. At the liver, roughly half of that flow perfuses hepatocytes while the other half bypasses the hepatic sinusoids through the first shunt, the ductus venosus, because the placenta already performs the liver's clearance and synthetic work and sparing the best blood from a slow, high-extraction organ keeps it available for the brain. The stream enters the inferior vena cava, where mixing brings saturation to about 67 percent, and reaches the right atrium. There the crista dividens and the Eustachian valve aim the inferior caval stream across the second shunt, the foramen ovale, into the left atrium, while blood from the superior vena cava at about 40 percent saturation is aimed instead at the tricuspid valve. This streaming means oxygenated blood preferentially fills the left side of the heart, so that the left ventricle ejects blood of about 65 percent saturation — the highest anywhere after the umbilical vein — into the ascending aorta and thence to the coronary arteries, head, neck, and arms. Blood entering the right ventricle at about 52 percent saturation is ejected into the pulmonary trunk, where only about 10 percent goes to the lungs because pulmonary vascular resistance is high in fluid-filled, hypoxically vasoconstricted lungs; the remaining 90 percent crosses the third shunt, the ductus arteriosus, into the descending aorta at about 58 percent saturation, supplying the lower body and returning to the placenta through the two umbilical arteries. At birth six changes occur in order: the first breath inflates the lungs and raises alveolar oxygen tension, releasing pulmonary vasoconstriction so pulmonary vascular resistance falls roughly tenfold within minutes; clamping the cord removes the large low-resistance placental bed so systemic vascular resistance rises abruptly; pulmonary venous return raises left atrial pressure above right atrial pressure, pressing septum primum against septum secundum and functionally closing the foramen ovale within minutes, though it fuses over months and remains probe-patent in about a quarter of adults; rising arterial oxygen tension together with the loss of placental prostaglandin E2 constricts the ductus arteriosus over ten to fifteen hours, with fibrosis by two to three weeks producing the ligamentum arteriosum; cessation of umbilical flow closes the ductus venosus within three to seven days, producing the ligamentum venosum; and the umbilical vein and arteries become the ligamentum teres of the liver and the medial umbilical ligaments respectively. The ventricles, which worked in parallel before birth, now work in series.

Development · When a Shunt Fails to Close

Each fetal shunt has a corresponding postnatal disease, and each disease is the shunt doing exactly what it was designed to do, at the wrong time.

Patent ductus arteriosus (PDA). In about 1 in 2,000 term births — and in up to 60% of infants born before 28 weeks — the ductus stays open. Preterm ductal tissue is less responsive to oxygen and more responsive to prostaglandin E₂, so the more premature the infant, the more likely the duct stays open. The consequence reverses the fetal pattern: after birth systemic resistance exceeds pulmonary resistance, so blood now flows left to right, from aorta into pulmonary artery. The lungs are flooded, the left heart is volume-overloaded, and diastolic pressure in the aorta falls as blood runs off into the pulmonary circuit — producing a wide pulse pressure, bounding pulses, and a continuous "machinery" murmur heard in both systole and diastole because the pressure gradient never reverses. Treatment is a prostaglandin synthesis inhibitor — indomethacin or ibuprofen — which is precisely the mechanism, run backwards.

Patent foramen ovale. About 25% of adults have a probe-patent foramen. Usually silent, because left atrial pressure normally holds the flap shut. But any maneuver that transiently raises right atrial pressure above left — a Valsalva, a cough, a pulmonary embolus — can open it, allowing a venous clot to cross into the systemic circulation: a paradoxical embolus, and a recognized cause of stroke in young adults with no other risk factors.

Duct-dependent lesions. In some severe congenital heart defects the entire systemic or pulmonary circulation depends on the duct staying open — transposition of the great arteries, hypoplastic left heart, critical coarctation, pulmonary atresia. Such infants are well at birth and collapse at 24–72 hours, exactly when the duct closes. The emergency treatment is an infusion of prostaglandin E₁ to hold the duct open, buying time for surgery. Knowing that one molecule keeps one shunt patent converts a lethal presentation into a manageable one.

Check Your Understanding 28.5

  1. Why does the fetal left ventricle receive better-oxygenated blood than the right, given that both are fed from the same venous return?
  2. A newborn is cyanotic and does not improve with supplemental oxygen. Explain why oxygen fails, in terms of shunt physiology.
Show answers
  1. Because of streaming, not mixing. The Eustachian valve and the crista dividens are anatomical baffles in the right atrium that aim the inferior vena caval stream — carrying the oxygenated umbilical venous return — across the foramen ovale into the left atrium, while the superior vena caval stream is directed downward across the tricuspid valve into the right ventricle. The right atrium is not a mixing chamber; it is a sorting chamber. The result is that the coronary and cerebral circulations, supplied from the ascending aorta, get the fetus's best blood.
  2. Because in a right-to-left shunt the desaturated blood never passes an alveolus. Supplemental oxygen raises the oxygen content of blood that reaches ventilated lung, but the shunted fraction bypasses the lung entirely and returns to the systemic circulation unchanged. Raising inspired oxygen from 21% to 100% therefore produces very little rise in arterial saturation — the basis of the hyperoxia test, which distinguishes cyanotic congenital heart disease from pulmonary causes of cyanosis in a newborn.

28.6 Maternal Adaptation, System by System

Pregnancy is not a state in which a woman carries a fetus while otherwise remaining herself. Nearly every organ system is remodeled, most of the changes begin in the first trimester — before the fetus is large enough to demand anything — and virtually all of them are driven by hormones rather than by mechanical load. That ordering is the key insight of this section: the mother's body prepares in advance for a demand that has not yet arrived.

Predict This

Plasma volume begins rising in week 6, when the entire conceptus weighs less than a gram, and is already up 25% by week 20. The fetus does not begin its steep growth until week 28.

Commit to an answer before reading on: if the extra volume is not needed yet, what is it for?

(Answer: two things, neither of them the fetus's current size. First, it lowers blood viscosity and fills a placental bed that is being built now and must be perfused low-resistance from the start. Second, it is a reserve against delivery: normal vaginal birth costs about 500 mL of blood and cesarean about 1,000 mL, and a woman who enters labor with 1,200 extra millilitres of plasma can lose that much without ever becoming hypovolemic. Pregnancy pre-loads the hemorrhage it knows is coming.)

Cardiovascular

Plasma volume rises 40–50% — from roughly 2,600 mL to 3,800–4,000 mL — beginning at week 6 and plateauing around weeks 32–34. The mechanism is hormonal: estrogen stimulates hepatic angiotensinogen synthesis and renin release, activating the renin–angiotensin–aldosterone system so that aldosterone rises three- to eight-fold and sodium is retained (net gain about 900–1,000 mEq across the pregnancy). Simultaneously, the hypothalamic osmostat is reset downward: plasma osmolality falls about 10 mOsm/kg and plasma sodium about 5 mEq/L, and the mother defends the new, lower value as normal rather than correcting it. Total body water rises 6.5–8.5 L.

Red cell mass rises 20–30% — from about 1,400 to 1,800 mL — driven by erythropoietin, human placental lactogen, and progesterone. Note that this is a real, substantial increase: the bone marrow is working harder than it ever has.

But 30% is less than 45%. Plasma expands faster than red cells, and hemoglobin concentration — which is a ratio, not a quantity — necessarily falls. This is the physiologic (dilutional) anemia of pregnancy. Hematocrit drops from about 40% to 33–34%, with the nadir at 28–32 weeks, exactly where Nia's 10.9 g/dL sits. The accepted thresholds for true anemia in pregnancy are correspondingly lowered: below 11.0 g/dL in the first and third trimesters, below 10.5 in the second.

Far from being a defect, the dilution is useful. Blood viscosity falls roughly 20%, and because resistance to flow is proportional to viscosity (Chapter 19), a less viscous blood perfuses the enormous low-pressure intervillous space more easily and is less prone to thrombose in it. The trade-off — slightly less oxygen per millilitre — is more than repaid by the increase in flow.

Cardiac output rises 30–50%, from about 4.5–5 L/min to 6–7 L/min, and Nia's ~40% rise is squarely typical. Both determinants contribute, but not simultaneously:

  • Stroke volume rises 20–30% (from ~65 to ~85 mL) and dominates the early rise, driven by the increased preload from plasma expansion and by ventricular remodeling — left ventricular mass increases 30–50% by eccentric hypertrophy, the chambers dilate, and end-diastolic volume rises. This is volume-overload remodeling, and it is reversible.
  • Heart rate rises 10–20 beats/min and dominates the later rise, as it does in Nia (76 → 88).

Where does the extra 2 L/min go? Almost all of it to beds that either serve the pregnancy or dissipate its heat:

Bed Non-pregnant Term Why
Uterus ~50 mL/min (2% of CO) 500–800 mL/min (17%) Placental perfusion
Kidneys ~1,000 mL/min +300–400 mL/min Clearing two individuals' waste
Skin ~300 mL/min +300–500 mL/min Dissipating fetal heat production
Breasts ~30 mL/min +200 mL/min Preparing for lactation

Meanwhile systemic vascular resistance falls 20–30%, and this is the reason the extra output does not translate into hypertension. Three mechanisms: progesterone, relaxin, nitric oxide, and prostacyclin relax vascular smooth muscle; the vasculature becomes markedly refractory to angiotensin II despite its elevated concentration; and the placenta itself is a large arteriovenous shunt of near-zero resistance dropped into the systemic circuit.

The consequence is counterintuitive and worth stating plainly: blood pressure falls in normal pregnancy. Diastolic pressure declines 10–15 mm Hg, reaching a nadir around 20–24 weeks and returning toward baseline by term. Nia's 102/58 at 28 weeks is not a warning sign; it is evidence that her vasculature is doing what it should.

Clinical Connection · Supine Hypotensive Syndrome — and Why It Matters in a Resuscitation

At term the gravid uterus weighs about 6 kg. When a woman lies flat on her back after roughly 20 weeks, that mass compresses the inferior vena cava against the vertebral column. Venous return falls by up to 25–30%, stroke volume follows, and cardiac output can drop 25% within minutes. Compensatory tachycardia and vasoconstriction hide it in most women, but 8–10% become frankly symptomatic — pale, nauseated, sweating, hypotensive, sometimes faint — within three to ten minutes of lying supine.

The fix is mechanical: left lateral tilt of 15–30°, or manual displacement of the uterus to the left, which rolls the mass off the cava. This is why pregnant patients are positioned on their left side for examinations, transport, and anesthesia.

The point at which this stops being a comfort issue and becomes a survival issue is cardiac arrest. Chest compressions generate cardiac output only if blood can return to the heart; with the cava obstructed, compressions in a supine pregnant patient are far less effective. Modern maternal resuscitation therefore mandates continuous manual left uterine displacement during CPR, and delivery of the fetus within 4–5 minutes if there is no return of circulation — not primarily to save the fetus, but because emptying the uterus is the fastest way to restore maternal venous return. An anatomical relationship dictates an entire resuscitation protocol.

Pregnancy is also a hypercoagulable state, and Virchow's triad is satisfied on all three counts: venous stasis from progesterone-mediated venodilation and caval compression, endothelial disturbance at delivery, and altered coagulation — fibrinogen rises 50% (300 → 450–600 mg/dL), factors VII, VIII, IX, X, and von Willebrand factor rise, protein S falls, and plasminogen activator inhibitors rise. Venous thromboembolism risk is four- to five-fold higher than in non-pregnant women of the same age, and higher still postpartum. Teleologically this is insurance against postpartum hemorrhage; clinically it is why thromboembolism remains a leading direct cause of maternal death.

Respiratory

Progesterone is a respiratory stimulant. It acts directly on the medullary respiratory centers and increases their sensitivity to CO₂, so the ventilatory response curve shifts left. The result is a 30–50% rise in minute ventilation (7.5 → 10.5 L/min) driven almost entirely by tidal volume (500 → 700 mL); respiratory rate barely changes. A pregnant woman who is breathing 24 times a minute is not hyperventilating because she is pregnant — look for another cause.

Arterial PCO₂ therefore falls to 28–32 mm Hg, from a non-pregnant 40. Blood pH would rise sharply, but the kidney excretes bicarbonate, bringing plasma HCO₃⁻ down to 18–22 mEq/L, and arterial pH settles at 7.40–7.45. This is a compensated respiratory alkalosis, and it is normal. Its purpose is the fetus: CO₂ must diffuse from fetal blood into maternal blood, and a maternal PCO₂ of 30 rather than 40 steepens that gradient by 25%.

Mechanically, the diaphragm rises about 4 cm and the subcostal angle widens from 68° to 103° as the ribs flare — so vital capacity is unchanged despite the uterus. What falls is functional residual capacity, by about 20%, because expiratory reserve and residual volume are both reduced. Combined with a 20–30% rise in oxygen consumption, this means a pregnant woman has a smaller oxygen store and a faster rate of using it: she desaturates during apnea two to three times faster than a non-pregnant adult. Every anesthetist knows this, and it is the reason obstetric airway management is treated as inherently high-risk.

Sixty to seventy percent of pregnant women report dyspnea — usually beginning in the first or second trimester, before the uterus is large. It is the sensation of a low PCO₂ and increased respiratory drive, not a sign of disease. Estrogen-driven mucosal capillary engorgement also produces nasal congestion, epistaxis, and a more friable, edematous upper airway.

Renal

The renal changes are the most quantitatively dramatic in the body, and they generate the most clinical misreadings.

GFR rises about 50%, from 100–120 to 150–180 mL/min, and does so by week 13 — long before the fetus needs it. Renal plasma flow rises 60–80%. The driver is relaxin, which increases endothelin and nitric oxide production and dilates both afferent and efferent arterioles; because both are dilated, flow rises steeply while glomerular capillary pressure does not — this is hyperfiltration without glomerular hypertension.

The consequences follow arithmetically:

  • Serum creatinine falls, from ~0.8 to ~0.5 mg/dL. Nia's 0.5 is normal for pregnancy. A creatinine of 1.0 mg/dL — an unremarkable value in a non-pregnant adult — represents roughly a halving of GFR in a pregnant woman and is distinctly abnormal. Blood urea nitrogen similarly falls from ~13 to ~9 mg/dL. Pregnancy resets the reference range, and using the non-pregnant range hides renal disease.
  • Glycosuria becomes normal. The filtered glucose load rises with GFR, but the proximal tubule's transport maximum for glucose does not. In roughly half of pregnant women glucose appears in the urine at entirely normal blood concentrations. Urine glucose is therefore useless for screening for gestational diabetes — a genuinely important negative result.
  • Protein excretion rises. Up to 300 mg/24 h is normal in pregnancy (versus 150 mg outside it), which is exactly why 300 mg is the diagnostic threshold for the proteinuria of preeclampsia.
  • Physiologic hydronephrosis. Progesterone relaxes ureteral smooth muscle and the enlarging uterus compresses the ureters at the pelvic brim — more on the right, because the uterus dextrorotates and the left ureter is cushioned by the sigmoid colon. Up to 300 mL of urine can sit stagnant in dilated collecting systems. As a result, asymptomatic bacteriuria progresses to pyelonephritis in 20–30% of untreated pregnant women, versus 1–2% otherwise, which is why asymptomatic bacteriuria is screened for and treated in pregnancy and ignored almost everywhere else.

Gastrointestinal, musculoskeletal, integumentary

Progesterone relaxes smooth muscle everywhere, and the gut pays for it. Lower esophageal sphincter tone falls while intra-abdominal pressure rises, producing heartburn in 40–80%. Gastric emptying is normal in pregnancy but markedly delayed in labor — the origin of the "nothing by mouth" rule and of the aspiration risk under anesthesia. Colonic transit slows and water reabsorption increases, giving constipation in about 40%. Gallbladder emptying is sluggish and bile becomes cholesterol-supersaturated, so gallstones form readily.

Nausea and vomiting affect 70–80%, beginning at 4–6 weeks, peaking at 8–12 weeks and resolving by 16–20 — a curve that tracks hCG closely. Severe, dehydrating hyperemesis gravidarum affects 0.3–2%.

Relaxin and progesterone loosen ligaments. The pubic symphysis widens from 3–4 mm to 7–8 mm and the sacroiliac joints soften, increasing pelvic outlet dimensions for delivery at the cost of stability. The center of gravity moves anteriorly and superiorly, lumbar lordosis increases to compensate, and 50–70% of women develop low back or pelvic girdle pain. Fluid retention in the carpal tunnel produces median nerve symptoms in up to 60%.

The skin darkens: estrogen and progesterone stimulate melanocytes, producing the linea nigra, areolar darkening, and melasma on the face in up to 70%. Striae gravidarum appear in 50–90% as dermal collagen and elastin fail under combined mechanical stretch and elevated cortisol. Estrogen-driven vasodilation produces spider angiomata and palmar erythema — the same signs seen in liver disease, and for the same reason, since a diseased liver fails to clear estrogen. Scalp hair is held in anagen throughout pregnancy and then releases synchronously two to four months postpartum: telogen effluvium, alarming and entirely self-limited.

Metabolic: an insulin resistance that is deliberate

Pregnancy has two metabolic halves.

Early pregnancy is anabolic. Maternal insulin sensitivity is normal or even increased, appetite rises, and the mother lays down 3–4 kg of fat — a strategic energy store for the third trimester and lactation.

Late pregnancy is deliberately diabetogenic. From about week 20, maternal insulin sensitivity falls by 50–60%, driven by human placental lactogen, placental growth hormone, progesterone, cortisol, and TNF-α — all of which rise with placental mass. Maternal pancreatic beta cells hypertrophy and insulin secretion rises two- to three-fold to compensate.

Why would a body deliberately break its own glucose control? Because glucose crosses the placenta by facilitated diffusion down a concentration gradient (§28.3). The fetus cannot pull glucose uphill; it can only take what the gradient gives it. Insulin resistance holds maternal post-meal glucose higher for longer, widening and prolonging that gradient at exactly the time the fetus's brain is growing fastest. Between meals, the mother switches rapidly to lipolysis and ketogenesis — accelerated starvation — so that her own tissues burn fat while glucose is reserved for the fetus. Fasting glucose actually falls in pregnancy (to 70–80 mg/dL) while post-prandial glucose rises. The mother is being rationed; the fetus is not.

Gestational diabetes mellitus is that adaptation overshooting maternal beta-cell reserve. It affects 6–9% of pregnancies (up to 14% with the most inclusive criteria) and is screened for at 24–28 weeks, precisely when hPL-driven resistance peaks. The fetal consequences follow directly from the transport rules: maternal glucose crosses, maternal insulin does not, so the fetus becomes hyperglycemic and secretes its own insulin — and insulin is a fetal growth hormone. The result is macrosomia with disproportionately large shoulders and trunk (raising the risk of shoulder dystocia and birth injury), neonatal hypoglycemia in the first hours as the glucose supply is cut at cord clamping while fetal hyperinsulinemia persists, polycythemia, hyperbilirubinemia, and delayed lung maturity, because insulin antagonizes cortisol's induction of surfactant. For the mother, gestational diabetes is a preview: 50–70% develop type 2 diabetes within 10–20 years. Pregnancy did not cause it. Pregnancy revealed it — a theme §28.9 will return to.

   MATERNAL CARDIOVASCULAR ADAPTATION ACROSS 40 WEEKS
   (% change from pre-pregnancy baseline; 0 = pre-pregnancy value)

   +50 ┤                              ╭──────── PLASMA VOLUME +45%
       │                         ╭────╯          (plateau wk 32–34)
   +40 ┤                    ╭────╯          ╭──── CARDIAC OUTPUT +40%
       │               ╭────╯          ╭────╯
   +30 ┤          ╭────╯          ╭────╯    ╭──── RED CELL MASS +25%
       │      ╭───╯          ╭────╯    ╭────╯
   +20 ┤   ╭──╯        ╭─────╯    ╭────╯     ╭─── STROKE VOLUME +25%
       │ ╭─╯      ╭────╯     ╭────╯     ╭────╯
   +10 ┤╭╯   ╭────╯     ╭────╯     ╭────╯  ╭───── HEART RATE +15%
       ├╯────╯     ╭────╯    ╭─────╯  ╭────╯
     0 ┼───────────┴─────────┴────────┴──────────────────────────
       │  ╲                                         ╱
   -10 ┤   ╲──╲                              ╱─────╯    ← DIASTOLIC BP
       │       ╲───╲                   ╱────╯             (nadir wk 20–24,
   -20 ┤            ╲──────────────╲──╯          ╭───     back to baseline
       │  ╲                                 ╱────╯        at term)
   -30 ┤   ╲──────────────────────────────╯    ← SYSTEMIC VASCULAR
       │                                          RESISTANCE −25%
       └──┬────┬────┬────┬────┬────┬────┬────┬────┬────┬────┬───
          4    8   12   16   20   24   28   32   36   40  DELIVERY
                                                          │
                        ┌─────────────────────────────────┴──────┐
                        │ IMMEDIATELY POST-DELIVERY:              │
                        │ contracting uterus AUTOTRANSFUSES       │
                        │ ~500 mL into the circulation, and caval │
                        │ compression is relieved →               │
                        │ CARDIAC OUTPUT SPIKES 60–80% ABOVE      │
                        │ PRE-LABOUR VALUES within 10–30 min.     │
                        │ This — not labour — is when women with  │
                        │ cardiac disease decompensate.           │
                        │ Baseline restored over 2–6 weeks.       │
                        └────────────────────────────────────────┘

   THE KEY READING: plasma volume (+45%) outruns red cell mass (+25%).
   Hemoglobin is a RATIO. It falls — to a nadir at 28–32 weeks — while
   the total number of red cells in the body is at an all-time high.

Figure 28.7 — Maternal cardiovascular adaptation plotted across 40 weeks and through delivery.

Described: A line graph plots percentage change from pre-pregnancy baseline against gestational week from 4 to 40 and beyond delivery. Rising curves show plasma volume climbing steadily from about week 6 to plateau near plus 45 percent at weeks 32 to 34; cardiac output rising to about plus 40 percent; red cell mass rising to about plus 25 percent; stroke volume rising to about plus 25 percent, with most of its rise occurring early; and heart rate rising to about plus 15 percent, with most of its rise occurring late. Falling curves show diastolic blood pressure declining to a nadir around weeks 20 to 24 and returning to baseline by term, and systemic vascular resistance falling by about 25 percent and remaining low. An annotation at delivery notes that the contracting uterus autotransfuses about 500 millilitres into the circulation while caval compression is relieved, so cardiac output spikes 60 to 80 percent above pre-labour values within ten to thirty minutes — the moment, rather than labour itself, at which women with cardiac disease decompensate — with baseline restored over two to six weeks. A closing note emphasises that plasma volume, at plus 45 percent, outruns red cell mass at plus 25 percent, and because hemoglobin concentration is a ratio it falls to a nadir at 28 to 32 weeks even though the total number of red cells in the body is at an all-time high.

Exercise & Sport · Training Through Pregnancy and Coming Back After It

Nia is a competitive runner, and the question she asked at her booking visit is the question almost every athletic patient asks: how much of this can I keep doing?

What the evidence supports. Current guidance from obstetric and sports medicine bodies converges on at least 150 minutes per week of moderate-intensity aerobic activity spread across most days, plus resistance training, for people with uncomplicated pregnancies. The measured benefits are substantial and consistent: roughly 25–40% lower incidence of gestational diabetes, 30–40% lower incidence of gestational hypertension and preeclampsia, less excessive gestational weight gain, reduced low back and pelvic girdle pain, better sleep, fewer depressive symptoms, a modestly shorter labor, and a lower cesarean rate. Birth weight is not reduced by moderate exercise, and preterm birth is not increased. Women who were athletes before pregnancy can generally continue their sport at a reduced intensity, and elite athletes have safely continued high-volume training under supervision.

The hemodynamic considerations, and why they are specific rather than vague.

  • Redistribution. During exercise, splanchnic and renal flow can fall 50–80% while muscle flow rises several-fold. Uterine flow does fall during moderate exercise — by perhaps 10–20% — but the placenta compensates by increasing oxygen extraction, and fetal heart rate rises 10–30 beats/min and recovers within minutes. Trained women develop a larger placental vascular volume, which is why they tolerate this better, not worse.
  • Preload and the supine position. After about 16–20 weeks, avoid prolonged supine exercise (flat bench work, supine core work) for the caval-compression reasons above.
  • Heat. Core temperature above roughly 39 °C in the first trimester is theoretically teratogenic. In practice, exercising women thermoregulate better in pregnancy — plasma volume is up and skin blood flow is up — and studies of moderate exercise have not shown core temperatures reaching that range. Hot yoga, saunas, and hot tubs are the genuine concerns.
  • Ventilation. Because functional residual capacity is down 20% and oxygen consumption up 20–30%, perceived exertion at a given workload rises. Rate of perceived exertion, or the talk test, is a better guide than heart rate, since resting heart rate has already risen 10–20 beats/min and maximum heart rate falls slightly.
  • Ligamentous laxity. Relaxin increases joint range of motion; sudden direction changes and deep end-range loading are less well controlled. Impact and balance risk, not cardiovascular risk, is what actually causes injury.

Absolute contraindications include significant cardiac or restrictive lung disease, incompetent cervix, persistent second- or third-trimester bleeding, placenta previa after 26 weeks, preterm labor, ruptured membranes, and preeclampsia. Warning signs to stop are vaginal bleeding, regular painful contractions, fluid leakage, dyspnea before exertion, chest pain, calf pain or swelling, and dizziness.

Coming back. The physiology of return is dominated by three things that recover on different timescales. Plasma volume and cardiac output normalize over 2–6 weeks. Relaxin-mediated joint laxity persists for 3–5 months, and longer while breastfeeding — which is why the athlete who feels cardiovascularly ready at six weeks is not yet mechanically ready. And the pelvic floor and abdominal wall need direct, progressive rehabilitation: some degree of diastasis recti is present in nearly all women at delivery and resolves in most by 8 weeks, and pelvic floor muscle training measurably reduces urinary incontinence. A sensible progression is walking and breath-coordinated pelvic floor work from days to weeks, low-impact aerobic work from 4–6 weeks, and a graded return to running from about 12 weeks, contingent on being able to run in place, hop, and single-leg squat without leakage or pain. There is no evidence that breastfeeding is impaired by exercise, and no meaningful effect on milk composition at ordinary intensities.

Aging · Advanced Maternal Age, and the Male Half of the Story

Nia is 24. Her mother Amara had her at 21. The physiology of doing this at 40 is different, and the difference is grounded in something established in Chapter 27: the oocyte pool is fixed before birth.

A female fetus has about 6–7 million oogonia at 20 weeks' gestation, 1–2 million at birth, 300,000–400,000 at puberty, and about 1,000 at menopause. No new ones are made. Every oocyte that Nia will ever ovulate entered prophase I in Nia's mother's uterus in 2001 and has been arrested there ever since.

That arrest is the mechanism of age-related aneuploidy. Homologous chromosomes are held together during arrest by cohesin complexes loaded onto the chromosomes before birth and never replenished. Over decades cohesin degrades, along with the protective protein shugoshin. Bivalents destabilize, kinetochores lose bi-orientation, and at the resumption of meiosis I the chromosomes segregate incorrectly. The clinical curve follows exactly:

Maternal age Risk of trisomy 21 at term Risk of any chromosomal abnormality
20 ~1 in 1,500 ~1 in 500
30 ~1 in 900 ~1 in 380
35 ~1 in 350 ~1 in 180
40 ~1 in 100 ~1 in 60
45 ~1 in 30 ~1 in 20

Note that this is a curve about chromosome mis-segregation, not about the uterus. Oocyte donation studies settle the question: a woman of 45 carrying an embryo from a 25-year-old donor oocyte has near-normal implantation and aneuploidy rates. The uterus ages gracefully. The oocyte does not.

Non-chromosomal risks do rise with maternal age for reasons that are cardiovascular and metabolic rather than genetic: gestational hypertension and preeclampsia, gestational diabetes, placenta previa, cesarean delivery, stillbirth, and preterm birth are all more common, largely because vascular compliance and endothelial function decline with age — the same substrate that §28.9 is about.

And the father. Male reproductive aging is real, slower, and mechanistically different. Spermatogonial stem cells divide continuously — roughly 23 divisions by puberty and about 23 more per year thereafter, so a sperm from a 20-year-old has undergone about 150 replication cycles and one from a 40-year-old about 610. Each replication is an opportunity for a copying error. The consequence is not aneuploidy but de novo point mutations, which accumulate at roughly two additional new mutations per year of paternal age, and which account for the majority of the ~70 new mutations in each newborn genome. This produces the paternal age effect seen in achondroplasia, Apert syndrome, and Marfan syndrome — all autosomal dominant conditions arising from new mutations — and contributes modestly to autism and schizophrenia risk. Semen volume, motility, and normal morphology also decline gradually from the late thirties, and time to conception lengthens.

The clean summary: maternal age is a chromosome-counting problem; paternal age is a copying-error problem. Chapter 29 explains both in molecular terms.

Check Your Understanding 28.6

  1. A 28-week pregnant woman has a hemoglobin of 10.8 g/dL and a ferritin of 60 ng/mL. Is she anemic? How would your answer change if the ferritin were 8 ng/mL?
  2. A pregnant patient's arterial blood gas shows pH 7.44, PaCO₂ 30 mm Hg, HCO₃⁻ 20 mEq/L. Is this normal? What would a PaCO₂ of 40 mm Hg mean in the same patient?
  3. Why does the standard non-pregnant reference range for serum creatinine cause renal disease to be missed in pregnancy?
Show answers
  1. No — a hemoglobin of 10.8 at 28 weeks is essentially at the expected nadir of physiologic hemodilution, and a ferritin of 60 ng/mL confirms adequate iron stores. This is dilution, not deficiency. With a ferritin of 8 ng/mL (below about 15 is diagnostic of iron depletion) the same hemoglobin means iron deficiency anemia superimposed on physiologic dilution, which is common — pregnancy requires roughly 1,000 mg of additional iron, more than most diets provide — and warrants supplementation. The lesson is that a hemoglobin value alone cannot distinguish the two, because one is a numerator problem and the other is a denominator problem.
  2. Normal for pregnancy. This is the expected compensated respiratory alkalosis: progesterone-driven hyperventilation lowers PaCO₂ to 28–32, renal bicarbonate excretion brings HCO₃⁻ to 18–22, and pH sits at the high-normal end. A PaCO₂ of 40 mm Hg — a perfectly normal value in a non-pregnant adult — would be alarming, because it means ventilation has fallen to non-pregnant levels despite a stimulus that should be driving it higher. In an asthmatic in status asthmaticus, a "normal" PaCO₂ is a sign of impending respiratory failure; in pregnancy it is doubly so.
  3. Because GFR rises about 50%, so the steady-state creatinine falls to roughly 0.5 mg/dL. A creatinine of 1.0 mg/dL sits comfortably inside the standard reference range of 0.6–1.1 and will be reported as normal, yet it represents roughly a halving of the patient's actual filtration rate. Since creatinine and GFR are related reciprocally rather than linearly, the early, most treatable decline is precisely where the reference range is most misleading. Pregnancy-specific ranges exist for this reason, and the same principle — that a normal number in an abnormal physiological context can be a pathological finding — recurs throughout clinical medicine.

28.7 Parturition

Gestation is conventionally dated from the first day of the last menstrual period: 280 days, or 40 weeks — about two weeks longer than the 266 days from conception. Term is 37–42 weeks, now subdivided into early term (37 0/7–38 6/7), full term (39 0/7–40 6/7), late term (41), and post-term (≥42), because outcomes differ measurably across those bands.

What starts labor

There is no single trigger. Labor begins when a set of restraints is withdrawn and a set of stimuli converges. Five processes matter.

1 · The fetus signals maturity. The fetal hypothalamic–pituitary–adrenal axis matures late in gestation and fetal cortisol rises steeply in the final weeks — the same cortisol that drives surfactant synthesis. In sheep, that cortisol induces placental 17α-hydroxylase and converts progesterone directly into estrogen. The human placenta lacks 17α-hydroxylase, so the human pathway is different: fetal cortisol stimulates placental CRH secretion. Uniquely in the body, placental CRH is stimulated rather than suppressed by cortisol — a positive feedback loop. Placental CRH rises exponentially from about 20 weeks, and its trajectory, measurable in maternal blood by mid-pregnancy, predicts the timing of delivery well enough to have earned the name the placental clock. CRH also drives fetal adrenal DHEA-S production, feeding estriol synthesis.

2 · The estrogen-to-progesterone balance shifts functionally. Progesterone is the myometrium's brake: it suppresses gap junction formation, oxytocin receptor expression, and prostaglandin synthesis. In most mammals, systemic progesterone falls before labor. In humans it does not. Instead there is a functional progesterone withdrawal — a shift in the ratio of progesterone receptor isoforms in the myometrium toward the transcriptionally inert PR-A, so that the same circulating progesterone concentration produces less effect. Estrogen action rises in relative terms and takes over.

3 · The myometrium becomes an electrical syncytium. Estrogen upregulates connexin-43, the protein of myometrial gap junctions, so that hundreds of thousands of smooth muscle cells become electrically coupled and can depolarize as one unit — the same principle that lets cardiac muscle contract synchronously (Chapter 18). A uterus that contracts in patches accomplishes nothing; a uterus that contracts as a unit generates pressure.

4 · Oxytocin receptors multiply. Myometrial oxytocin receptor density rises 100- to 200-fold between early pregnancy and term. Circulating oxytocin barely changes. The switch is the receptor, not the hormone — which is why an oxytocin infusion at 28 weeks does very little and the same infusion at 40 weeks reliably produces labor.

5 · Prostaglandins do the mechanical work. PGE₂ and PGF₂α from decidua and amnion do two things at once: they contract myometrium, and they ripen the cervix — activating collagenases that break down the dense collagen network, drawing in hyaluronic acid and water, and converting a rigid 3-cm cylinder into a soft, thin, distensible ring. This is why NSAIDs (prostaglandin synthesis inhibitors) delay labor and are used as tocolytics, and why misoprostol, a PGE₁ analogue, induces it.

The positive feedback loop

Once contractions begin, the loop that finishes the job is the cleanest example of biological positive feedback in the human body — the one introduced in Chapter 1, §1.5, and promised then for this chapter.

   THE OXYTOCIN POSITIVE FEEDBACK LOOP OF LABOUR
   (compare Figure 1.3 — the same four boxes, opposite sign)

        ┌──────────────────────────────────────────────────────────┐
        │                                                          │
        ▼                                                          │
   ╔═══════════════════════╗                                       │
   ║  STIMULUS             ║   fetal presenting part pushes         │
   ║  CERVICAL STRETCH     ║   downward on the cervix               │
   ╚═══════════╤═══════════╝                                       │
               │                                                    │
               ▼                                                    │
   ┌───────────────────────┐                                        │
   │ RECEPTOR              │  stretch receptors in cervix           │
   │ mechanoreceptors      │  and lower uterine segment             │
   └───────────┬───────────┘                                        │
               │  AFFERENT: pelvic splanchnic nerves →              │
               │  spinal cord → hypothalamus                        │
               ▼                                                    │
   ┌───────────────────────┐                                        │
   │ CONTROL CENTRE        │  paraventricular & supraoptic nuclei   │
   │ HYPOTHALAMUS          │  of the hypothalamus                   │
   └───────────┬───────────┘                                        │
               │  EFFERENT: axonal transport down the               │
               │  infundibulum → POSTERIOR PITUITARY                │
               ▼                                                    │
   ┌───────────────────────┐                                        │
   │ EFFECTOR              │  OXYTOCIN released into blood          │
   │ MYOMETRIUM            │       │                                │
   │ (+ decidua)           │       ├──► myometrial contraction      │
   └───────────┬───────────┘       │    (needs the 100–200×         │
               │                   │     receptor upregulation)     │
               │                   └──► decidual PROSTAGLANDIN      │
               │                        release → MORE contraction  │
               ▼                                                    │
   ╔═══════════════════════╗                                       │
   ║  RESPONSE             ║   fetus driven harder against the      │
   ║  stronger contraction ║   cervix → MORE STRETCH ───────────────┘
   ╚═══════════════════════╝        AMPLIFICATION, not correction

   ═════════════════════════════════════════════════════════════════════
   WHY THIS IS SAFE:  every physiological positive feedback loop has a
   BUILT-IN ENDPOINT that removes the stimulus. Here, DELIVERY of the
   fetus ends cervical stretch, the afferent signal stops, oxytocin
   falls, and the loop terminates. Compare: clotting stops when the
   vessel is sealed; the action potential stops when Na⁺ channels
   inactivate. A positive loop without a terminator is a disease.
   ═════════════════════════════════════════════════════════════════════

Figure 28.8 — The oxytocin positive feedback loop of labor, drawn on the standard control-loop template.

Described: A closed loop drawn on the same four-box template used for negative feedback in Chapter 1, but with the sign reversed. The stimulus is cervical stretch produced by the fetal presenting part pushing down on the cervix. The receptors are mechanoreceptors in the cervix and lower uterine segment. The afferent pathway runs through pelvic splanchnic nerves and the spinal cord to the hypothalamus. The control centre is the paraventricular and supraoptic nuclei of the hypothalamus. The efferent pathway is axonal transport down the infundibulum to the posterior pituitary, which releases oxytocin into the blood. The effector is the myometrium, which contracts — an effect that requires the hundred- to two-hundred-fold upregulation of oxytocin receptors at term — together with the decidua, which releases prostaglandins that further strengthen contraction. The response drives the fetus harder against the cervix, producing more stretch and closing the loop with amplification rather than correction. A closing note explains why this is safe: every physiological positive feedback loop has a built-in endpoint that removes the stimulus. Here delivery of the fetus ends cervical stretch, the afferent signal stops, oxytocin falls, and the loop terminates — just as clotting stops when the vessel is sealed and the action potential stops when sodium channels inactivate. A positive loop without a terminator is a disease.

The stages of labor

Stage 1 — Dilation. From the onset of regular contractions to full cervical dilation at 10 cm. The longest stage by far. A latent phase (to about 6 cm) is slow and variable — 6–20 hours in a first pregnancy — and an active phase follows at roughly 1.2–1.5 cm/hour. Contractions begin 15–30 minutes apart and lasting 20–30 seconds, and end 2–3 minutes apart and lasting 60–90 seconds. The cervix simultaneously effaces, thinning from 3 cm to paper-thin. The amniotic sac usually ruptures during this stage.

Stage 2 — Expulsion. Full dilation to delivery of the infant: 20 minutes to 2 hours in a first labor (longer with epidural analgesia), often minutes in a subsequent one. The fetus executes the cardinal movements — engagement, descent, flexion, internal rotation, extension, external rotation (restitution), and expulsion — and the reason they exist is skeletal. The pelvic inlet is widest transversely; the pelvic outlet is widest anteroposteriorly. A head that enters facing sideways must therefore rotate roughly 90° during descent to exit facing backward. This is the obstetrical dilemma: bipedal locomotion narrowed and reoriented the human pelvis while encephalization enlarged the fetal head, and human birth is the geometric compromise. No other primate requires assistance at delivery, and essentially every human culture provides it.

Stage 3 — Placental. Delivery of the placenta, 5–30 minutes later. The uterus contracts down; because the placenta cannot shrink with it, it shears off along a plane of fibrinoid degeneration in the decidua. Then comes the mechanism that makes childbirth survivable: the myometrium's interlacing fiber bundles contract around the spiral arteries that supplied the placenta, compressing them shut. This is the living ligature. Normal blood loss is 300–500 mL from a bed that was receiving 500–800 mL per minute — the vessels are sealed by muscle, not by clot. When the uterus fails to contract (uterine atony), that same bed bleeds at arterial rates; atony is the leading cause of postpartum hemorrhage worldwide, and the first-line treatments — uterine massage, oxytocin, misoprostol — all do one thing: make the muscle contract.

Stage 4 — Immediate recovery. The first one to two hours, when hemorrhage risk is highest.

The puerperium

The six weeks after delivery reverse nine months of adaptation.

  • Uterine involution. From about 1,000 g to 60–80 g, by autolysis of muscle cytoplasm rather than by cell death. The fundus is at the umbilicus immediately after delivery and no longer palpable abdominally by two weeks. Lochia — the shedding decidua — progresses from rubra (red, days 1–4) to serosa (pink-brown, days 4–10) to alba (white-yellow, up to six weeks).
  • Cardiovascular. As Figure 28.7 shows, cardiac output rises immediately after delivery before it falls, and returns to baseline over 2–6 weeks. A diuresis of about 3 L in the first week clears the retained fluid.
  • Coagulation. Hypercoagulability persists 6–12 weeks; thromboembolic risk is actually higher postpartum than antepartum.
  • Mood. Transient "postpartum blues" affect 50–80% in days 3–10, coinciding with the abrupt withdrawal of placental steroids. Postpartum depression — persistent, functionally impairing, and requiring treatment — affects 10–15%, and is a distinct entity, not an intensification of the blues.

28.8 Lactation

Preparing the gland

The breast is not functional at conception. Across pregnancy, estrogen drives ductal proliferation, progesterone drives lobuloalveolar development, and prolactin, human placental lactogen, cortisol, insulin, and growth hormone act permissively. Maternal prolactin rises from 10–20 ng/mL to 200–400 ng/mL by term.

So why is there no milk before delivery, with prolactin already ten times normal? Because progesterone blocks prolactin's action at the alveolar cell, suppressing prolactin receptor expression and the synthesis of milk proteins. The gland is fully built, fully stimulated, and held shut by a single hormone.

Delivery of the placenta removes the source of that hormone. Progesterone falls more than 90% within 48 hours, the block lifts, and copious milk secretion — lactogenesis II — begins at 30–72 hours: "the milk coming in." The mechanism has a clean natural experiment attached to it: retained placental fragments delay lactogenesis, and removing them starts it.

Colostrum and mature milk

Colostrum (days 1–4) Mature milk (from ~2 weeks)
Volume 40–50 mL/day 700–800 mL/day
Energy ~55 kcal/100 mL 65–70 kcal/100 mL
Protein 2–3 g/dL, IgA-rich 0.9–1.1 g/dL, whey:casein 60:40
Fat Low 3.5–4.5 g/dL (hindmilk 2–3× foremilk)
Lactose Low ~7 g/dL
Sodium/chloride High Low
Secretory IgA 2–5 g/L 0.5–1 g/L

Colostrum's small volume is not a deficiency — it matches a newborn stomach that holds 5–7 mL on day one. Its composition matches the newborn's actual first-day problem, which is not calories but colonization: it is essentially a dose of immunoglobulin, lactoferrin, growth factors, and oligosaccharides delivered to a sterile gut, plus enough osmotic effect to clear meconium.

Two reflexes, two loops

Milk production and milk delivery are controlled by different hormones, through different pituitary lobes, on different timescales. Confusing them is the most common error in this topic, so hold them apart deliberately.

PROLACTIN reflex — production OXYTOCIN reflex — ejection
Stimulus Suckling (nipple mechanoreceptors) Suckling — and sight, sound, or thought of the infant
Pathway Afferent → hypothalamus → inhibits dopamine release Afferent → paraventricular and supraoptic nuclei
Gland Anterior pituitary lactotrophs Posterior pituitary (neurosecretion)
Hormone Prolactin (surges 10–20× within 30 min) Oxytocin (pulsatile)
Target Alveolar secretory epithelium Myoepithelial cells around alveoli
Effect Synthesis of lactose, casein, lipid Contraction → milk moves into ducts
Latency This feed's prolactin makes the next feed's milk 30–60 seconds — "let-down"
Inhibited by Dopamine agonists (cabergoline suppresses lactation) Catecholamines: pain, stress, embarrassment
Enhanced by Dopamine antagonists (some antipsychotics cause galactorrhea) Conditioning — a baby's cry can trigger it

Two features are worth dwelling on. First, prolactin is the only anterior pituitary hormone under dominant inhibitory control: the hypothalamus restrains it with dopamine rather than releasing it with a releasing hormone. Cut the pituitary stalk and every other anterior pituitary hormone falls while prolactin rises. Second, the oxytocin reflex is a genuine neuroendocrine reflex with a conditioned component — it can be triggered by a photograph and blocked by embarrassment, because catecholamines both inhibit oxytocin release centrally and constrict the vessels delivering it to the breast.

Local control completes the system. Milk contains a feedback inhibitor of lactation, a whey protein that accumulates when milk is not removed and suppresses further synthesis in that breast. Supply is therefore regulated per breast, on a demand basis, without any systemic signal — which is why frequent removal increases supply and why a woman can feed one infant from one side.

Prolactin also suppresses GnRH pulsatility, suppressing LH and preventing ovulation: lactational amenorrhea, which under strict conditions (exclusive breastfeeding, amenorrhea, infant under six months) is about 98% effective as contraception and remains, globally, the most widely used method of birth spacing.

The immunological content

Milk is not only food. Roughly a quarter of its protein content is not digested at all but acts in the infant's gut lumen.

  • Secretory IgA — dimeric, protease-resistant, and produced by plasma cells that migrated to the breast from the mother's own gut and airway (the entero-mammary link). It is therefore targeted at exactly the organisms the mother is currently exposed to, which are exactly the organisms the infant is about to meet. It works by immune exclusion: it binds pathogens in the lumen and prevents adherence, without triggering inflammation.
  • Lactoferrin binds iron with extremely high affinity, starving iron-dependent bacteria.
  • Lysozyme, present at thousands of times its concentration in cow's milk, lyses bacterial cell walls.
  • Human milk oligosaccharides are the third-largest solid component and are entirely indigestible by the infant. They exist to feed Bifidobacterium and to act as decoy receptors that bind pathogens instead of the gut epithelium.
  • Living leukocytes, 10⁵–10⁶ per mL, along with cytokines, growth factors, and hormones.

Note the complementarity with the placenta. IgG crosses the placenta, enters the fetal bloodstream, and protects systemically for six to nine months. IgA is delivered in milk, is not absorbed, and protects the mucosal surface. Two immunoglobulin classes, two delivery routes, two compartments — a division of labor arranged before the infant has any immune system of its own.

Clinical Connection · Sheehan Syndrome — Reading a Pituitary From a Breast

The anterior pituitary enlarges by up to 135% in pregnancy, mostly from lactotroph hyperplasia, and its blood supply is a low-pressure portal system. Enlarged tissue plus a low-pressure supply is a vulnerable combination, and a severe postpartum hemorrhage with hypotension can infarct it: Sheehan syndrome.

The presentation is a diagnostic gift, because the first symptom is usually failure of lactation. Prolactin is gone, the alveoli are never stimulated, and the milk never comes in. Amenorrhea follows as gonadotropins fail, then fatigue and cold intolerance as TSH fails, then — most dangerously — adrenal insufficiency as ACTH fails, which may not declare itself until the next physiological stress.

The clinical logic runs backwards through the whole system: an absent secretory product implies an absent trophic hormone, which implies a specific dead cell population, which implies a vascular event at a specific time. And note the contrast with the posterior pituitary, which has a direct arterial supply and is usually spared, so diabetes insipidus is uncommon — an anatomical detail with a diagnostic consequence.

Check Your Understanding 28.8

  1. A woman delivers, and 5 days later has still produced no milk despite frequent nursing. Give two mechanistically distinct explanations.
  2. Why can a woman's milk supply increase in response to a growth spurt without any change in her circulating prolactin concentration?
Show answers
  1. (a) Retained placental fragments. Continuing placental progesterone secretion maintains the block on prolactin action at the alveolar cell, so lactogenesis II cannot begin. Removing the fragments releases it — the natural experiment that proves the mechanism. (b) Sheehan syndrome — pituitary infarction after postpartum hemorrhage, so no prolactin is secreted at all. These are opposite failures: one is an intact signal that is being blocked at the target, the other is the signal never being sent. Distinguishing them is a matter of measuring prolactin and asking about the third stage of labour and blood loss.
  2. Because of local autocrine control. The feedback inhibitor of lactation is a protein in the milk itself; when milk is removed more frequently, its concentration in the alveoli falls and its suppression of synthesis is lifted. This operates within a single breast and requires no systemic hormonal change — which is also why supply matches demand so precisely, and why "pumping to increase supply" works.

28.9 Advanced Topic · Preeclampsia and the Long Reach of the Placenta

Thread 3 · The Body Is Integrated

Hold two facts side by side. The placenta is a temporary organ, genetically foreign to the mother, that will be delivered and discarded. And preeclampsia — a disease that begins in that organ, in the first trimester, at the interface between trophoblast and a hundred small maternal arteries — produces hypertension, proteinuria, liver injury, thrombocytopenia, hemolysis, pulmonary edema, and seizures.

How does a local defect in one organ become a disease of every organ? Because the mediator it releases travels in the blood, and the tissue it damages is present in every organ: the endothelium. Preeclampsia is the clearest demonstration in this book that a disease is defined by the distribution of its target, not by the location of its cause.

Preeclampsia affects 3–5% of pregnancies and remains among the leading causes of maternal and perinatal death worldwide. It is defined as new-onset hypertension (≥140/90 mm Hg on two occasions at least four hours apart) after 20 weeks of gestation, plus either proteinuria (≥300 mg/24 h, or a urine protein:creatinine ratio ≥0.3) or, in its absence, evidence of end-organ dysfunction: platelets below 100,000/µL, creatinine above 1.1 mg/dL or doubled, transaminases twice normal, pulmonary edema, or new cerebral or visual symptoms.

Notice that this definition names consequences scattered across five organ systems and says nothing about where the disease is. That reflects two centuries of describing a syndrome before understanding it. The mechanism is now reasonably well established, and it has two stages.

Stage 1 · The placental stage — a failure of remodeling, weeks 8–18

In a normal pregnancy, extravillous cytotrophoblast cells stream out of the anchoring villi and invade the decidua and then the inner third of the myometrium, in two waves — around weeks 8–10 and weeks 16–18. What they do there is extraordinary: they invade the walls of the maternal spiral arteries, replace the endothelium, and destroy the smooth muscle and elastic lamina.

The consequence of destroying the muscle is the entire point. Roughly 100 spiral arteries are converted from narrow (200 µm), muscular, vasoreactive resistance vessels into wide (500–1,000 µm), flaccid, low-resistance conduits that cannot constrict. Diameter rises four- to six-fold; flow rises perhaps thirty-fold; and — critically — flow becomes independent of maternal vasomotor tone. The placenta cannot be starved by a sympathetic surge, a catecholamine release, or a bout of exercise, because the vessels supplying it have had their contractile apparatus surgically removed by fetal cells.

In preeclampsia, the second wave fails. Invasion stops at the decidual–myometrial junction. The myometrial segments of the spiral arteries keep their muscle, keep their responsiveness, and keep their high resistance. The result is not constant ischemia but something worse: intermittent perfusion, with cycles of hypoxia and reoxygenation that generate reactive oxygen species and place the syncytiotrophoblast under sustained oxidative stress. Why the invasion fails is not fully settled; the leading candidates involve abnormal interaction between fetal HLA-C and maternal uterine NK cell KIR receptors, maternal endothelial or metabolic predisposition, and immune maladaptation to paternal antigens (which is why a first pregnancy, and a pregnancy with a new partner, both carry higher risk).

All of this is complete by about 18–20 weeks, and the woman is entirely asymptomatic.

Stage 2 · The maternal stage — an antiangiogenic state, from 20 weeks

The stressed syncytiotrophoblast releases substances into the maternal circulation. The most important is sFlt-1 (soluble fms-like tyrosine kinase 1), a truncated, soluble version of the VEGF receptor-1 that lacks a membrane anchor. Free in the plasma, it binds VEGF and placental growth factor (PlGF) and prevents them from ever reaching the VEGF receptors on endothelial cells. Alongside it comes soluble endoglin, which sequesters TGF-β and blocks activation of endothelial nitric oxide synthase, plus syncytiotrophoblast microparticles, cell-free fetal DNA, and agonistic autoantibodies against the angiotensin II type 1 receptor.

Circulating sFlt-1 begins to rise about five weeks before clinical disease appears, and the sFlt-1 : PlGF ratio is now used clinically — a ratio below 38 rules out preeclampsia developing within the next week with high negative predictive value.

Here is the step that makes everything else follow. Endothelium is not a passive lining; it requires continuous VEGF signaling to maintain itself. This is especially true of fenestrated endothelium — the glomerulus, the liver sinusoids, the choroid plexus — where podocytes and neighboring cells supply VEGF locally and constantly. Withdraw it and the endothelium swells, loses its fenestrations, becomes leaky and prothrombotic, and stops making nitric oxide and prostacyclin.

The most persuasive evidence for this mechanism comes from oncology. Bevacizumab and other anti-VEGF drugs, given to cancer patients of both sexes, cause hypertension in 20–30% and proteinuria in a substantial minority, with renal biopsies showing the same glomerular endotheliosis found in preeclampsia. The same molecular lesion, produced by a drug instead of a placenta, produces the same syndrome in people who are not pregnant. That is about as close to a controlled experiment as human physiology offers.

One lesion, every organ

Sign Endothelial mechanism
Hypertension Less NO and prostacyclin, more endothelin-1 and thromboxane; loss of normal pregnancy's refractoriness to angiotensin II → systemic vascular resistance rises instead of falling
Proteinuria Glomerular endotheliosis: swollen endothelial cells occlude capillary lumens and lose fenestrations; podocyte injury follows. GFR falls, so creatinine and uric acid rise
Edema, pulmonary edema Increased capillary permeability plus reduced plasma oncotic pressure from protein loss. Plasma volume is contracted, not expanded — a rising hematocrit in a preeclamptic woman is a severity marker, the exact inverse of the physiologic dilution of §28.6
Right upper quadrant pain, raised transaminases Periportal fibrin deposition and hepatocyte necrosis; stretching of the liver capsule. Subcapsular hematoma in severe cases
Thrombocytopenia and hemolysis Damaged endothelium consumes platelets and shears red cells passing through fibrin strands — microangiopathic hemolysis with schistocytes, high LDH, low haptoglobin. Together: HELLP syndrome, in 10–20% of severe cases
Headache, visual scotomata, seizures Loss of cerebral autoregulation plus a leaky blood–brain barrier → vasogenic edema, characteristically posterior on MRI. Seizure = eclampsia
Fetal growth restriction, oligohydramnios, abruption The placenta that started it is itself underperfused. Abnormal umbilical artery Doppler is often the first objective sign

Treatment follows from the mechanism, and so do its limits. The only definitive treatment is delivery of the placenta, because the placenta is the source. Antihypertensives (labetalol, nifedipine, hydralazine) do not treat the disease; they protect the mother's brain from hemorrhagic stroke. Magnesium sulfate prevents eclamptic seizures — halving their incidence — and it is not an antihypertensive: it acts as a cerebral vasodilator, an NMDA receptor antagonist, and a membrane stabilizer. Antenatal corticosteroids buy fetal lung maturity between 24 and 34 weeks. And because sFlt-1 takes days to clear after delivery, preeclampsia can present or worsen up to six weeks postpartum — a fact that kills women who are discharged and told the danger has passed.

Prevention — and why Nia's aspirin starts at 12 weeks

Low-dose aspirin, 81–162 mg daily, started between 12 and 16 weeks and continued to delivery, reduces preterm preeclampsia by roughly 60% in high-risk women. Aspirin irreversibly acetylates cyclooxygenase-1. Platelets have no nucleus and cannot resynthesize the enzyme, so their thromboxane A₂ production is suppressed for their entire lifespan; endothelial cells, which have nuclei, resynthesize COX and continue making prostacyclin. The net effect is a shift in the thromboxane:prostacyclin balance toward vasodilation and away from platelet aggregation — precisely the balance that endothelial dysfunction disturbs. There is also evidence that aspirin improves trophoblast invasion directly.

The timing is not arbitrary. Spiral artery remodeling is complete by 18–20 weeks. Aspirin started at 12 weeks can influence a process still underway; aspirin started at 24 weeks cannot. This is a therapeutic decision made entirely on embryological grounds.

Nia has two moderate risk factors — nulliparity, and a first-degree relative (Amara) with hypertension and chronic kidney disease — plus a family history of hypertension in her grandmother. Under current guidance, two or more moderate risk factors is an indication for prophylaxis. That is the whole reason she is on 81 mg from 12 weeks.

Clinical Connection · Rh Incompatibility — the Placenta's Transport System Turned Against the Fetus

An RhD-negative woman carrying an RhD-positive fetus has no problem in the first pregnancy. Fetal red cells enter her circulation in small numbers throughout gestation and in larger numbers at delivery, at miscarriage, after abdominal trauma, or after amniocentesis. Her primary immune response produces IgM, which is a pentamer far too large to cross the placenta. That pregnancy is safe.

The next one is not. Memory B cells now produce IgG anti-D on re-exposure, and IgG is not merely permitted across the placenta — it is actively transported by the neonatal Fc receptor (§28.3). Maternal antibody coats fetal red cells, which are destroyed in the fetal spleen: hemolytic disease of the fetus and newborn. The fetus becomes anemic, mounts extramedullary hematopoiesis in liver and spleen, develops high-output cardiac failure, and in severe cases accumulates fluid in every compartment — hydrops fetalis. After birth, the bilirubin released by hemolysis is no longer being cleared by the maternal liver and can cross the immature blood–brain barrier to cause kernicterus.

The elegance of the prevention is worth appreciating. Anti-D immune globulin (300 µg at 28 weeks and within 72 hours of delivery, plus after any sensitizing event) is passive antibody given to prevent active antibody. It binds and clears fetal red cells from the maternal circulation before maternal B cells can be primed, and additionally delivers inhibitory signals to those B cells. Sensitization rates have fallen from 13–16% to under 0.1%.

The lesson connects directly to §28.3: the FcRn transport system exists to give the newborn six months of maternal immunity, and it has no way to distinguish a protective antibody from a destructive one. A transport mechanism is not a judgment. This material is developed further in Chapter 17.

Clinical Connection · The Developmental Origins of Adult Disease — and Amara

In the winter of 1944–45 the western Netherlands was subjected to a food embargo. Rations fell to 400–800 kcal/day for about five months, and then, abruptly, the war ended and food returned. The cohort conceived and gestated during that window has been followed for more than seventy years, and it is the closest thing developmental biology has to a controlled human experiment.

The findings are consistent and specific to timing. Those exposed in early gestation were born at normal weight but had, six decades later, higher rates of obesity, atherogenic lipid profiles, and coronary artery disease — and measurably reduced methylation of the IGF2 gene, still detectable in blood at age 60. Those exposed in late gestation were born smaller and showed higher rates of glucose intolerance.

This is the empirical basis of the Barker hypothesis, or the developmental origins of health and disease. Across many populations, low birth weight is inversely associated with adult coronary disease, hypertension, and type 2 diabetes. The proposed mechanism — the thrifty phenotype — is that a fetus receiving signals of scarcity remodels itself for a scarce world: fewer nephrons, altered pancreatic beta-cell mass, a reset hypothalamic–pituitary–adrenal axis, stiffer arteries, altered appetite regulation. The prediction is adaptive if it is correct, and costly if the world turns out to be rich instead. Disease arises from mismatch.

The nephron example is the most concrete. Human nephron number varies more than tenfold between individuals — roughly 210,000 to 2.7 million per kidney — is fixed by 36 weeks' gestation, and correlates with birth weight. A person born with a low nephron endowment must run each glomerulus at a higher filtration rate for life. Chronic hyperfiltration causes glomerulosclerosis, which reduces nephron number further, which raises filtration in the survivors. That is a positive feedback loop with a decades-long time constant, and it presents in the fifth decade as hypertension and chronic kidney disease.

Which brings us to Amara. She has hypertension, coronary disease, type 2 diabetes, and stage 3 chronic kidney disease at 45. Some of that is behavioral, some is twenty years of night shift, and some is genetic — Chapter 29 quantifies that part. But some of it may have been set before she was born, in the uterus of the woman who now sits in her waiting room with hypertension of her own.

And Nia is pregnant. Her placenta is currently establishing the nutrient environment in which a third generation's nephron number, beta-cell mass, and vascular elasticity are being determined. The mechanism by which a prenatal environment writes a durable instruction into a genome it cannot change is epigenetic, and it is the last section of the next chapter.

Imaging · Reading the Placenta Without Seeing It

Preeclampsia is a placental disease, and the placenta is the one organ in the pregnancy that routine ultrasound examines least. Three indirect measurements are used instead, and each reads a different part of the mechanism.

Uterine artery Doppler (20–24 weeks). Successful spiral artery remodeling converts a high-resistance bed into a low-resistance one, which shows up upstream as a loss of the early diastolic notch in the uterine artery waveform and a fall in the pulsatility index. A persistent notch or a raised pulsatility index at 20–24 weeks means the remodeling of §28.9 stage 1 did not happen properly. It is a direct sonographic read of a histological event that finished weeks earlier.

Umbilical artery Doppler (third trimester). As described in §28.3, rising placental resistance reduces, then abolishes, then reverses end-diastolic flow. This tracks the fetal consequence of the same lesion.

Middle cerebral artery Doppler and the cerebroplacental ratio. A hypoxic fetus dilates its cerebral vessels to preserve brain perfusion — "brain sparing" — so middle cerebral artery resistance falls. When the ratio of cerebral to umbilical resistance inverts, the fetus is actively compensating, and the ratio predicts adverse outcome better than either vessel alone.

Notice what all three have in common: none of them images a disease. They image resistance — a physiological quantity — in three vascular beds, and the diagnosis is inferred from the pattern. This is functional imaging in the strict sense of Chapter 1, done with sound.

Check Your Understanding 28.9

  1. A woman at 33 weeks has BP 158/104, proteinuria, platelets of 78,000/µL, and a hematocrit of 42%. Her hematocrit at 20 weeks was 33%. Why is the rising hematocrit significant?
  2. Why does delivering the baby not immediately cure preeclampsia?
Show answers
  1. Because normal pregnancy produces a falling hematocrit through plasma expansion (§28.6). A rise from 33% to 42% means the plasma volume has contracted — fluid has left the intravascular space through leaky endothelium and been lost to the interstitium as edema. Hemoconcentration is therefore a direct measure of capillary leak and a recognized marker of disease severity. It also warns that the patient is intravascularly depleted despite being grossly edematous, which is why aggressive fluid loading in preeclampsia causes pulmonary edema rather than correcting anything. The same number that signals health when it falls signals danger when it rises.
  2. Because the mediators have a half-life. Delivering the placenta removes the source of sFlt-1 and soluble endoglin, but circulating levels take several days to clear, and the endothelial dysfunction they caused takes longer still to resolve. Roughly a quarter of eclamptic seizures occur after delivery, and preeclampsia can present de novo up to six weeks postpartum. Magnesium sulfate is therefore continued for 24 hours after delivery, and blood pressure is monitored for weeks — not because the disease might come back, but because it has not yet left.

Thread 2 · Homeostasis Is the Master Concept

Everything in §28.6 is a homeostatic system that has had its set point deliberately moved — the same phenomenon Chapter 1 introduced with fever.

The osmostat is reset downward, and the mother defends a plasma sodium of 133 as though it were 140. The ventilatory CO₂ set point is reset downward, and she defends a PaCO₂ of 30. The renal threshold for glucose is functionally lowered. The tolerated protein excretion is doubled. Blood pressure is defended at a lower value. Insulin sensitivity is reset to a level that would be called disease in anyone else.

Not one of these is a failure. Every one is a control system whose target has been shifted by placental hormones to serve a second organism, and every one returns to its original value within weeks of delivery. Which is why the single most important skill in obstetric medicine is knowing the pregnancy-specific reference range — because in pregnancy, a normal number is often the abnormal finding.


Chapter Summary

§28.1 Sperm require capacitation in the female tract before they can fertilize. Fertilization occurs in the ampulla: sperm penetrate the corona radiata, the acrosomal reaction digests a channel through the zona pellucida, and IZUMO1–JUNO binding fuses the membranes. Sperm-derived PLCζ triggers calcium oscillations that drive the cortical reaction (the decisive slow block to polyspermy), release meiosis II arrest, and initiate development. Syngamy produces the diploid zygote.

§28.2 Cleavage divides without growth, producing a morula by day 3 and a blastocyst by day 5, with trophoblast (placenta) and inner cell mass (embryo) already separated. Implantation occurs days 6–7; the syncytiotrophoblast invades the endometrium and secretes hCG by day 8. The inner cell mass becomes the bilaminar disc with amnion above and yolk sac below. Monozygotic twins share whatever had already formed at the moment of splitting, which is why the day of splitting determines chorionicity and amnionicity.

§28.3 The placenta forms from chorionic villi and decidua basalis. Maternal and fetal blood are separated at term by a 2 µm barrier across 12–14 m². Its four functions are exchange (oxygen by diffusion at low PO₂, glucose by facilitated diffusion, amino acids by active transport), endocrine (hCG, progesterone, estriol via the fetoplacental unit, hPL, CRH), immune tolerance (absent classical MHC, HLA-G, uterine NK cells, regulatory T cells), and a barrier that alcohol, most drugs, many viruses, and IgG all cross. Umbilical arteries carry deoxygenated blood away from the fetal heart; the vein carries oxygenated blood toward it.

§28.4 Gastrulation at day 15 converts the bilaminar disc into three germ layers, all derived from epiblast. Neurulation closes the cranial neuropore at day 25 and the caudal at day 27–28 — before most pregnancies are recognized, which is why folate must be periconceptional. Folding converts a flat disc into a cylinder. Weeks 3–8 are the period of maximum teratogenic susceptibility because every organ is being assembled; weeks 1–2 are all-or-none, and from week 9 insults cause functional rather than structural damage.

§28.5 The fetus grows and matures. Surfactant appears at ~24 weeks and becomes adequate at 34–36; weight roughly doubles in the last eight weeks. Three shunts — ductus venosus, foramen ovale, ductus arteriosus — bypass the liver and the fluid-filled, high-resistance lungs, letting the ventricles work in parallel and directing the best-oxygenated blood to brain and heart. At birth, lung inflation drops pulmonary resistance, cord clamping raises systemic resistance, and all three shunts close in sequence, leaving ligaments behind.

§28.6 Plasma volume rises 40–50% and red cell mass 20–30%, so hemoglobin — a ratio — falls: the physiologic anemia of pregnancy. Cardiac output rises 30–50% while systemic vascular resistance falls 20–30%, so blood pressure declines. Progesterone drives hyperventilation to a PaCO₂ of 28–32 with compensated alkalosis; FRC falls 20%. GFR rises 50% by week 13, so creatinine falls and glycosuria and mild proteinuria become normal. Late pregnancy imposes deliberate insulin resistance to hold maternal glucose high for placental transfer; gestational diabetes is that adaptation exceeding beta-cell reserve.

§28.7 Labor begins when fetal cortisol drives placental CRH, functional progesterone withdrawal releases the myometrial brake, gap junctions and oxytocin receptors multiply 100–200-fold, and prostaglandins ripen the cervix. Cervical stretch then drives a positive feedback loop through hypothalamic oxytocin release, terminated by delivery. Three stages: dilation, expulsion (with the cardinal movements dictated by pelvic geometry), and placental separation sealed by the living ligature of contracting myometrium.

§28.8 Progesterone withdrawal at delivery releases prolactin's block and lactogenesis II begins at 30–72 hours. Prolactin makes milk; oxytocin moves it. Prolactin is uniquely under inhibitory (dopaminergic) control; oxytocin ejection is a conditionable neuroendocrine reflex inhibited by catecholamines. Local feedback inhibitor of lactation matches supply to demand per breast. Milk delivers secretory IgA to the mucosa, complementing the IgG the placenta delivered to the blood.

§28.9 Preeclampsia begins with failed second-wave trophoblast invasion, leaving spiral arteries muscular and vasoreactive. The resulting ischemia–reperfusion stress releases sFlt-1 and soluble endoglin, which sequester VEGF and PlGF and produce systemic endothelial dysfunction — which is why one placental lesion damages kidney, liver, brain, platelets, and lung simultaneously. Only delivery removes the source; aspirin from 12 weeks prevents 60% of preterm cases by acting while remodeling is still underway. Gestational diabetes, Rh disease, and the Barker hypothesis all illustrate the same theme: the intrauterine environment writes consequences that outlast it.

The Three Threads in Chapter 28

Structure → Function. The syncytiotrophoblast is a syncytium because a sheet without cell junctions has no paracellular leak — the placenta's selectivity is a cytological fact. The zona pellucida hardens because ZP2 is cleaved. The fetal pelvis dictates the cardinal movements. And the destruction of spiral artery smooth muscle by invading trophoblast is the structural change on which the entire success of the pregnancy depends.

Homeostasis. Pregnancy is a systematic, reversible resetting of set points — osmolality, PaCO₂, blood pressure, GFR, insulin sensitivity — to serve a second organism. Labor is one of the body's three physiological positive feedback loops, safe only because delivery removes the stimulus.

Integration. A defect in trophoblast invasion at week 16 becomes a seizure at week 34, because the mediator travels in blood and the target — endothelium — is everywhere. And a maternal nutritional environment becomes a grandchild's blood pressure, because development writes instructions that outlive the conditions that produced them.


Case File 28 · Resolution

Question 1 — Why does pregnancy raise cardiac output by 40%? What needs the extra flow, and how does the heart manage it?

Three destinations account for essentially all of the extra 2 L/min, and only one of them is the fetus.

  • The uterus and placenta. Uterine flow rises from about 50 mL/min to 500–800 mL/min at term — from 2% to roughly 17% of cardiac output. The intervillous space is a low-resistance reservoir that must be flushed three to four times a minute to keep the maternal-side oxygen tension high enough to drive diffusion across a barrier that is only 2 µm thick but faces a maternal PO₂ of only 40–50 mm Hg. Placental exchange is flow-limited, so more flow is literally more oxygen delivered.
  • The kidneys. Renal plasma flow rises 60–80% and GFR 50%, because the mother is now clearing the metabolic waste of two individuals — and because relaxin dilates both afferent and efferent arterioles.
  • The skin. Skin blood flow rises several-fold, because the fetus is a continuous heat source with no independent means of losing heat. Every calorie the fetus generates must leave through the mother's skin.

Smaller contributions go to the breasts (+200 mL/min) and to a larger circulating volume in general.

How the heart manages it is the second half of the question, and the answer is that it barely has to work harder in the sense that matters. Cardiac output is stroke volume times heart rate, and both rise — stroke volume by 20–30% early (driven by a 40–50% plasma volume expansion raising preload, and by eccentric ventricular remodeling that adds 30–50% to left ventricular mass), heart rate by 10–20 beats/min later. Nia's rise from 76 to 88 is the heart-rate component; the rest is volume.

Crucially, systemic vascular resistance falls 20–30% at the same time, driven by progesterone, relaxin, nitric oxide and prostacyclin, by vascular refractoriness to angiotensin II, and by the placenta itself acting as a large low-resistance shunt. Because arterial pressure is roughly the product of cardiac output and resistance, output can rise 40% while pressure falls. The heart is pumping much more blood into a much more open circuit — which is volume work, not pressure work, and is far better tolerated. Nia's blood pressure of 102/58 at 28 weeks is the direct evidence that this is exactly what happened.

Question 2 — Why does hemoglobin fall in a healthy pregnancy when the woman is making more red cells?

Because hemoglobin concentration is a ratio, and pregnancy increases the denominator faster than the numerator.

Red cell mass rises 20–30%, from about 1,400 mL to about 1,800 mL. That is a real increase, and it requires substantial erythropoietic effort and roughly 500 mg of additional iron. But plasma volume rises 40–50%, from about 2,600 mL to nearly 4,000 mL. Divide a 25% larger red cell mass by a 45% larger total volume and the concentration falls, even though the absolute number of red blood cells in Nia's body — and therefore her total oxygen-carrying capacity — has never been higher in her life.

Her hemoglobin at booking was 11.6 g/dL and at 28 weeks 10.9 g/dL. The nadir of physiologic hemodilution falls at 28–32 weeks, which is precisely where she is, and the pregnancy-specific threshold for anemia in the third trimester is 11.0 g/dL. She is, on paper, marginally "anemic." Physiologically she is normal, and the way to prove it is a ferritin — a measure of iron stores that dilution does not affect.

The dilution is not a side effect to be tolerated. It is useful. Blood viscosity falls about 20%, and since flow resistance is proportional to viscosity, less viscous blood perfuses the huge, slow, low-pressure intervillous space more easily and is less likely to thrombose there. And the extra 1,200 mL of plasma is a hemorrhage reserve: normal vaginal delivery costs about 500 mL and cesarean about 1,000 mL, and a woman who begins labor with that much surplus volume can lose it without ever becoming hypovolemic.

Question 3 — How can a disease of the placenta cause hypertension, kidney damage, and seizures in the mother?

Because the placenta does not act locally. It secretes into the maternal bloodstream, and what it secretes when it is ischemic attacks a tissue that lines every vessel in the body.

The chain, in order:

  1. Weeks 8–18: failed remodeling. Extravillous trophoblast normally invades the maternal spiral arteries and destroys their smooth muscle, converting about 100 narrow, vasoreactive resistance vessels into wide, flaccid, low-resistance conduits. In preeclampsia the second wave of invasion fails, and the myometrial segments retain their muscle.
  2. Placental ischemia. Vessels that can still constrict deliver intermittent perfusion. Cycles of hypoxia and reoxygenation subject the syncytiotrophoblast to oxidative stress.
  3. Release of antiangiogenic factors. The stressed placenta sheds sFlt-1 — a soluble VEGF receptor with no membrane anchor — and soluble endoglin into maternal blood. sFlt-1 binds circulating VEGF and PlGF and prevents them from ever reaching endothelial receptors.
  4. Systemic endothelial dysfunction. Endothelium requires continuous VEGF signaling to maintain itself, especially the fenestrated endothelium of the glomerulus and liver. Deprived of it, endothelial cells swell, lose fenestrations, leak, become prothrombotic, and stop producing nitric oxide and prostacyclin.
  5. Everything else follows from where endothelium is. Vessels everywhere → vasoconstriction and hypertension. Glomerulus → glomerular endotheliosis, proteinuria, falling GFR, rising creatinine and uric acid. Capillaries everywhere → leak, edema, pulmonary edema, and a paradoxically contracted plasma volume with a rising hematocrit. Liver sinusoids → fibrin deposition, transaminase rise, right upper quadrant pain. Damaged endothelial surfaces → platelet consumption and shearing of red cells: HELLP syndrome. Cerebral vessels → loss of autoregulation and vasogenic edema → headache, scotomata, and eclamptic seizures.

So the answer to "how can an organ that will be discarded cause this?" is that the disease was never confined to the placenta. The placenta is only the source. The disease is in the maternal endothelium, which is why it touches every organ and why the only cure is removing the source — and why, since sFlt-1 takes days to clear, it does not end the moment the placenta is delivered.

Nia is on aspirin from 12 weeks for exactly this reason: aspirin can shift the thromboxane–prostacyclin balance and improve trophoblast invasion while step 1 is still happening. By 20 weeks, that window has closed.


Systems Integration Case File · Entry 28

Entry 28 — A second patient, and a second generation

Until now your file has had one center of gravity: Amara. This entry adds a person, and it adds a system that exists only temporarily.

New findings — Nia Osei-Barrett, 28 weeks' gestation.

Measurement Value Interpretation
Blood pressure 102/58 mm Hg Below her own pre-pregnancy baseline
Heart rate 88 beats/min +12 from booking
Hemoglobin 10.9 g/dL Ferritin 48 ng/mL (stores adequate)
Estimated cardiac output ~6.9 L/min +40% from ~4.9
Plasma volume +45% Red cell mass +25%
Serum creatinine 0.5 mg/dL Was 0.8 pre-pregnancy
24-h urine protein 190 mg Normal in pregnancy (< 300)
Uric acid 3.4 mg/dL Low-normal
1-h 50-g glucose challenge 118 mg/dL Normal (< 140)
Uterine artery Doppler, 22 wk No diastolic notch, normal PI Remodeling succeeded
Fundal height 28 cm Appropriate
Medication Aspirin 81 mg daily since week 12 Preeclampsia prophylaxis
Activity 4 easy miles, 4×/week; no supine core work Tolerating well

Your entry:

1 · ADD. In two or three sentences, state what the placenta contributes to Nia's physiology that no permanent organ does, and name the two measurements above that are direct evidence her placenta is working normally.

2 · CONNECT. Link Nia's pregnancy to at least two systems already in your file, stating the direction of causation in each case. At least one link must run backwards in time — that is, connect a finding in Nia's pregnancy to something you have already recorded about Amara.

3 · PREDICT. Chapter 29 is genetics. Name one thing you expect it to say about why Amara has coronary disease at 45 and Nia does not at 24 — and say whether you think the difference is genetic, temporal, or both.

Model responses — read only after writing your own

1 · ADD. The placenta is simultaneously Nia's fetus's lung, kidney, gut, and liver, and the largest endocrine organ her body will ever contain — secreting the hPL that has made her 50–60% insulin resistant, the progesterone that has lowered her vascular resistance and slowed her gut, and the estrogen that expanded her plasma volume by 45%. It is also a near-zero resistance arteriovenous shunt dropped into her systemic circuit, which is why her cardiac output is up 40% while her blood pressure is down. The two measurements that most directly evidence normal placental function are the uterine artery Doppler at 22 weeks with no diastolic notch — proving that trophoblast invasion successfully destroyed the smooth muscle of her spiral arteries — and the fundal height of 28 cm at 28 weeks, indicating a fetus growing normally on the flow that remodeling made possible. A third, subtler one: her uric acid of 3.4 is low, as it should be with a GFR up 50%, and rising uric acid is one of the earliest signals of preeclampsia.

2 · CONNECT. Cardiovascular → renal: the 40% rise in cardiac output and the relaxin-mediated dilation of both afferent and efferent arterioles raise Nia's GFR by 50%, which causes her creatinine to fall from 0.8 to 0.5 — the same variable that, moving in the opposite direction, defines Amara's stage 3 chronic kidney disease. Hematologic → cardiovascular: plasma volume expansion of 45% outpaces the 25% rise in red cell mass, which causes her hemoglobin to fall to 10.9 while lowering blood viscosity, which lowers resistance to flow in the intervillous space and improves placental perfusion. Endocrine → metabolic: placental lactogen causes insulin resistance, which causes higher post-meal maternal glucose, which causes greater facilitated diffusion of glucose to the fetus — the same insulin resistance that in Amara, unopposed by a pregnancy and sustained for twenty years, became type 2 diabetes. Backwards in time: Amara's own intrauterine environment may have set her nephron endowment and beta-cell mass (§28.9), which would mean that part of the chronic kidney disease she has at 45 was determined before she was born — and that Nia's placenta is currently doing the same job for a third generation.

3 · PREDICT. Both, and the honest answer is that they are not separable. Nia has inherited half of Amara's genome, so roughly half of whatever polygenic burden Amara carries is in Nia too; a genetic risk score would likely place Nia well above average. But coronary disease is not a switch that flips at a genotype — it is the integral of exposure over time. Amara has had twenty additional years of elevated LDL, elevated blood pressure, elevated glucose, and night-shift-disrupted circadian physiology acting on the same arterial wall. Nia has had none. The prediction is that Chapter 29 will show the family carries no single broken gene but a high polygenic burden, and that the age difference is mostly the accumulation of exposure, not the emergence of a genotype — which would mean Nia's risk is real, distant, and unusually modifiable.


Review

Level 1 · Recall

24.1 Capacitation of sperm occurs:

a) in the epididymis    b) in the female reproductive tract    c) at the moment of ejaculation    d) within the seminiferous tubules

Answer

b — in the female reproductive tract, over 6–8 hours. Cholesterol and seminal glycoproteins are stripped from the membrane, calcium permeability rises, and motility becomes hyperactivated. This is why in vitro fertilization requires a capacitation medium: a sperm straight from the ejaculate cannot fertilize. (a) is where sperm gain motility, a different maturation; (d) is where they are made.

24.2 The decisive block to polyspermy in humans is:

a) membrane depolarization    b) the corona radiata    c) the cortical reaction hardening the zona pellucida    d) the second polar body

Answer

c. Calcium released by sperm-derived PLCζ triggers cortical granule exocytosis; ovastacin cleaves ZP2 and the zona loses its sperm-binding capacity within about a minute. Membrane depolarization (a) is the classic "fast block," robustly demonstrated in sea urchins but weak in mammals. The corona (b) is penetrated by many sperm. The polar body (d) is a mechanism for discarding chromosomes, not for excluding sperm.

24.3 The inner cell mass of the blastocyst gives rise to:

a) the placenta    b) the chorionic villi    c) the embryo    d) the decidua

Answer

c — the embryo, plus the amnion, yolk sac, and allantois. The trophoblast gives rise to (a) and (b). The decidua (d) is maternal tissue — transformed endometrial stroma — and is not derived from the conceptus at all. Note that on day 5 about 99% of cells are trophoblast: the embryo proper is built from a small minority.

24.4 Which structure allows blood to bypass the fetal lungs?

a) ductus venosus    b) foramen ovale    c) ductus arteriosus    d) both b and c

Answer

d — both. The foramen ovale shunts blood from right atrium to left atrium, and the ductus arteriosus shunts blood from pulmonary trunk to descending aorta; each bypasses the pulmonary circulation at a different point, and together they divert about 90% of right ventricular output. The ductus venosus (a) bypasses the liver, not the lungs.

24.5 Hemoglobin falls in normal pregnancy because:

a) red cell production decreases    b) iron is diverted to the fetus    c) plasma volume rises proportionally more than red cell mass    d) hemolysis increases

Answer

c. Plasma volume rises 40–50% while red cell mass rises 20–30%, so the concentration falls even though the absolute red cell count is at an all-time high. (a) is the opposite of the truth — erythropoiesis is increased. (b) is a real phenomenon and can cause a second, superimposed iron-deficiency anemia, but it is not the cause of physiologic hemodilution; a ferritin distinguishes them. (d) does not occur in normal pregnancy.

24.6 Maternal serum creatinine in normal pregnancy:

a) rises to about 1.3 mg/dL    b) falls to about 0.5 mg/dL    c) is unchanged    d) becomes undetectable

Answer

b — falls to about 0.5 mg/dL, because GFR rises about 50% by week 13. The clinical consequence is the trap: a creatinine of 1.0 mg/dL sits inside the standard non-pregnant reference range and will be reported as normal, yet in a pregnant woman it represents roughly a halving of filtration.

24.7 The hormone principally responsible for maternal insulin resistance in late pregnancy is:

a) hCG    b) human placental lactogen    c) oxytocin    d) relaxin

Answer

b — human placental lactogen, with contributions from placental growth hormone, progesterone, cortisol, and TNF-α. Its secretion rises with placental mass, which is why insulin resistance peaks in the third trimester and why gestational diabetes is screened for at 24–28 weeks. hCG (a) peaks at 8–10 weeks and rescues the corpus luteum; oxytocin (c) drives labor and milk ejection; relaxin (d) mediates ligamentous laxity and renal vasodilation.

24.8 Milk ejection (let-down) is mediated by:

a) prolactin from the anterior pituitary    b) oxytocin from the posterior pituitary    c) estrogen from the placenta    d) the feedback inhibitor of lactation

Answer

b — oxytocin from the posterior pituitary, contracting myoepithelial cells around the alveoli within 30–60 seconds. Prolactin (a) drives milk synthesis, not ejection, and works on a delay of a full feed. Keeping these two loops apart is the single most testable idea in the lactation material.

Level 2 · Comprehension

24.9 Explain why a defect in trophoblast invasion during weeks 8–18 produces maternal seizures at 34 weeks.

Model answer

Failed second-wave invasion leaves the myometrial segments of the spiral arteries muscular and vasoreactive, so the intervillous space is perfused intermittently rather than continuously. Cycles of hypoxia and reoxygenation impose oxidative stress on the syncytiotrophoblast, which responds by releasing sFlt-1 and soluble endoglin into the maternal circulation. sFlt-1 binds VEGF and PlGF and prevents them from reaching endothelial VEGF receptors. Endothelium throughout the body requires continuous VEGF signaling to maintain itself, so it swells, becomes leaky, becomes prothrombotic, and stops producing nitric oxide and prostacyclin.

In the brain, this combination — systemic hypertension plus a leaky blood–brain barrier plus loss of cerebral autoregulation — permits vasogenic edema, characteristically in the posterior circulation. Edema in the cortex lowers the seizure threshold. The seizure is therefore separated from its cause by about eighteen weeks and by four causal steps, none of which involves the brain until the last one.

24.10 A newborn is delivered at 30 weeks and develops respiratory distress. Explain the underlying physiology and why a corticosteroid given to the mother two days before delivery would have helped.

Model answer

Type II pneumocytes begin producing surfactant around 24 weeks but do not produce adequate amounts until 34–36 weeks. Without sufficient surfactant, alveolar surface tension is high; by Laplace's law the collapsing pressure of a small alveolus exceeds that of a large one, so small alveoli empty into large ones and progressively collapse at end-expiration. The infant must generate very large negative pressures to reopen them with each breath, work of breathing rises, atelectasis and ventilation–perfusion mismatch develop, and hypoxemia follows — neonatal respiratory distress syndrome.

Cortisol is the physiological trigger for surfactant synthesis, which is exactly why fetal cortisol rises in the last weeks of gestation. A synthetic corticosteroid given to the mother crosses the placenta readily (it is small and lipid-soluble) and acts on fetal type II pneumocytes to induce surfactant protein and phospholipid synthesis, with a measurable effect within 24–48 hours. The drug is not doing anything new; it is anticipating a fetal signal that would otherwise arrive too late. Betamethasone and dexamethasone are used specifically because they are poorly inactivated by placental 11β-hydroxysteroid dehydrogenase and therefore reach the fetus, unlike cortisol or prednisolone.

24.11 Both labor and blood clotting are positive feedback loops. Explain what makes each safe, and name one clinical situation in which a normally safe positive loop becomes lethal.

Model answer

Both have a built-in terminator that removes the stimulus. In labor, the stimulus is cervical stretch; the loop amplifies until delivery, at which point stretch ends, the afferent signal stops, oxytocin falls, and the loop switches off. In clotting, the stimulus is exposed subendothelial collagen; the loop amplifies until the plug covers the breach, at which point the stimulus is physically hidden and the loop stops. In both cases termination is structural, not regulatory — the loop does not decide to stop, it runs out of stimulus.

A normally safe positive loop becomes lethal when the terminator is absent. Cardiogenic shock is the example from Chapter 1: falling cardiac output lowers coronary perfusion, which worsens myocardial ischemia, which lowers cardiac output further, with nothing in the loop to end it. Disseminated intravascular coagulation is the clotting version — widespread activation with no localized breach to seal, consuming platelets and factors until the patient bleeds. And in obstetrics specifically, amniotic fluid embolism triggers exactly that cascade.

Level 3 · Clinical Application

24.12 A woman at 34 weeks presents with a headache and epigastric pain. BP 162/108. Platelets 68,000/µL. AST 210 U/L. Hematocrit 43% (was 32% at 20 weeks). Urine protein:creatinine 0.9. Explain each abnormal value in terms of a single underlying lesion, and explain why giving her two litres of intravenous fluid would be dangerous.

Model answer

Every value is a consequence of systemic endothelial dysfunction caused by placentally derived antiangiogenic factors — this is severe preeclampsia with HELLP features.

  • BP 162/108 — endothelial cells are producing less nitric oxide and prostacyclin and more endothelin-1 and thromboxane; the vasculature has also lost normal pregnancy's refractoriness to angiotensin II. Systemic vascular resistance rises instead of falling.
  • Proteinuria (P:C 0.9) — glomerular endotheliosis. Swollen endothelial cells lose their fenestrations and occlude capillary lumens; podocytes are injured; protein escapes.
  • AST 210 — periportal fibrin deposition and hepatocyte necrosis. The epigastric pain is stretch of the liver capsule, and it is an ominous symptom because it can precede subcapsular hematoma and hepatic rupture.
  • Platelets 68,000 — damaged endothelium activates and consumes platelets, and red cells are sheared passing through fibrin strands (microangiopathic hemolysis). Together with the transaminases this is HELLP.
  • Hematocrit 43%, up from 32% — this is the key number. Normal pregnancy dilutes; a rise means plasma has leaked out of the vasculature into the interstitium. She is hemoconcentrated and intravascularly depleted while being grossly edematous.
  • Headache — cerebral vasogenic edema. This is a warning of impending eclampsia and is why magnesium sulfate is indicated.

Why two litres of fluid is dangerous: her capillaries leak, and her plasma oncotic pressure is reduced by urinary protein loss. Infused crystalloid does not stay intravascular; it moves into the interstitium, and the lung is the interstitium that matters. Pulmonary edema is a leading cause of death in preeclampsia and is very often iatrogenic. The low intravascular volume is a symptom of the leak, not a deficit to be replaced. Management is magnesium for seizure prophylaxis, controlled blood pressure reduction to protect against hemorrhagic stroke, judicious fluid restriction, and delivery.

24.13 A term newborn is pink and vigorous at birth. At 30 hours of age he becomes grey, tachypneic, and poorly perfused, with weak femoral pulses. Explain the physiology and the immediate pharmacological intervention.

Model answer

The timing is diagnostic. Deterioration at 24–72 hours of life, after an entirely normal first day, is the signature of a duct-dependent congenital heart lesion — here the weak femoral pulses point to critical coarctation of the aorta or interrupted aortic arch.

In utero, the descending aorta and lower body are supplied largely by the ductus arteriosus carrying right ventricular output, so an obstruction in the aortic arch is entirely bypassed and the fetus is unaffected. After birth, rising arterial oxygen tension and the loss of placental PGE₂ cause the ductus to constrict over 10–15 hours and functionally close by about 24–72 hours. At that moment, the lower body's only remaining supply is through the obstructed segment. Systemic perfusion collapses, producing shock, metabolic acidosis, and absent or weak lower-limb pulses with preserved upper-limb pulses.

The immediate intervention is an infusion of prostaglandin E₁ (alprostadil) to reopen and maintain ductal patency, restoring lower-body perfusion and buying time for echocardiography and surgery. It is worth appreciating the symmetry: indomethacin, a prostaglandin synthesis inhibitor, is used to close a persistently patent duct in a preterm infant, and prostaglandin E₁ is used to hold one open here. The same molecule, used in both directions, according to which way the shunt physiology needs to go.

24.14 A woman who has just delivered has a boggy, poorly contracted uterus and is losing blood at an estimated 800 mL over ten minutes. Explain why the bleeding is occurring and why uterine massage and oxytocin are first-line, in mechanistic terms.

Model answer

At term the placental bed receives 500–800 mL/min — 10–17% of maternal cardiac output — through about 100 spiral arteries that trophoblast invasion deliberately stripped of their smooth muscle (§28.9). Those vessels cannot constrict, which is exactly what made the pregnancy work and exactly what makes the third stage dangerous. Nothing in the vessel wall can stop the bleeding.

Hemostasis after placental separation is therefore not vascular and not primarily coagulative. It is mechanical: the interlacing bundles of myometrium contract around the spiral arteries and occlude them from the outside — the living ligature. A uterus that fails to contract (atony) leaves those vessels wide open at arterial pressure, which is why atony is the commonest cause of postpartum hemorrhage and why the blood loss can be so rapid.

Uterine massage mechanically stimulates myometrial contraction; oxytocin acts on the myometrial oxytocin receptors, still massively upregulated from term, to do the same pharmacologically. Second-line agents — misoprostol (a prostaglandin), methylergonovine, carboprost — all likewise force contraction. Every first-line treatment for postpartum hemorrhage is aimed at one target: make the muscle squeeze. Note also that a woman entering delivery with a 45% expanded plasma volume can lose this much and remain normotensive, which is a real benefit and a real trap, because normal vital signs can mask ongoing loss until compensation abruptly fails.

Level 4 · Integration and Synthesis

24.15 Nia's cardiac output is up 40% and her blood pressure is down. Amara's cardiac output is normal-to-low and her blood pressure is 168/98. Both women have activated renin–angiotensin–aldosterone systems. Explain how the same hormonal axis produces opposite blood pressures, and what this reveals about how blood pressure is actually determined.

Model answer

Mean arterial pressure is the product of cardiac output and systemic vascular resistance. Both women have raised RAAS activity, but the vascular response to angiotensin II is opposite, and that is decisive.

In Nia, estrogen has raised hepatic angiotensinogen synthesis and renin activity, and aldosterone is elevated three- to eight-fold — driving the sodium retention that expands plasma volume by 45% and, through preload, raises cardiac output 40%. But normal pregnancy makes the vasculature markedly refractory to angiotensin II, and simultaneously floods it with progesterone, relaxin, nitric oxide, and prostacyclin, while inserting the placenta — a large low-resistance arteriovenous shunt — into the circuit. Systemic vascular resistance falls 20–30%. Output rises 40%, resistance falls 25%, and the product falls slightly. Her 102/58 is the arithmetic result.

In Amara, RAAS activation is driven by reduced renal perfusion from her chronic kidney disease and by sympathetic activation, and her vasculature is not refractory to angiotensin II — it is, if anything, hyper-responsive, because endothelial dysfunction from twenty years of hypertension, hyperglycemia, and dyslipidemia has reduced nitric oxide availability. The same hormone therefore produces vasoconstriction, resistance rises, sodium retention raises volume without a compliant bed to accommodate it, and pressure rises. Her heart, already impaired, cannot raise output against that resistance.

What this reveals: blood pressure is not set by any hormone. It is set by the interaction between a hormone and the responsiveness of the tissue it acts on — and the tissue in question is the endothelium. Two women with the same hormonal signal and opposite endothelial states have opposite pressures. That is the same principle §28.9 used to explain preeclampsia, in which the pregnant vasculature loses its angiotensin II refractoriness and begins to behave like Amara's. Preeclampsia is, in this sense, a pregnancy in which the vascular adaptation failed and the RAAS activation was left unopposed.

24.16 Construct the full causal chain linking Adwoa's pregnancy in 1980 to Amara's chronic kidney disease in the present, and then to Nia's fetus. Identify at each step which evidence is strong and which is inference, and state what would falsify the chain.

Model answer

The chain.

  1. Adwoa's nutritional and vascular state during pregnancy determined the intrauterine environment of the fetus who became Amara.
  2. Fetal nutrient restriction — or placental insufficiency, or maternal hypertension — reduces fetal growth and, specifically, nephron endowment, which is fixed by 36 weeks and never increases. Human nephron number varies more than tenfold and correlates with birth weight.
  3. A low nephron endowment means each glomerulus must filter at a higher rate for life. Chronic single-nephron hyperfiltration causes glomerulosclerosis, which removes nephrons, which raises filtration in those remaining — a positive feedback loop with a decades-long time constant.
  4. Reduced nephron mass also impairs sodium excretion, which raises blood volume and blood pressure, which accelerates both glomerular and systemic vascular injury.
  5. Hypertension plus insulin resistance plus dyslipidemia accelerate coronary atherosclerosis and further nephron loss, presenting as Amara's current picture: hypertension, coronary disease, type 2 diabetes, and stage 3 CKD at 45.
  6. Nia inherits half of Amara's genome and is gestating in her own uterus a fetus whose nephron endowment, beta-cell mass, and vascular elasticity are being set right now.

Evidence versus inference. Strong: nephron number is fixed prenatally and varies tenfold; birth weight correlates inversely with adult hypertension, coronary disease, and type 2 diabetes across many large cohorts; the Dutch Hunger Winter cohort shows outcome differences that depend on the trimester of exposure, which is very hard to explain by anything other than development; hyperfiltration causes glomerulosclerosis in animal models and in humans with reduced renal mass. Inference: that Amara specifically had a low nephron endowment — we have no measurement, and nephron number cannot currently be counted in a living person. That Adwoa's pregnancy specifically was compromised. That the epigenetic marks observed in the Dutch cohort are causal rather than correlated markers.

What would falsify it. Ideally, a measured birth weight for Amara in the normal range, combined with a normal kidney size and no evidence of reduced renal reserve, would remove step 2 for her personally. More broadly, the hypothesis predicts that the association between low birth weight and adult disease should persist after full adjustment for shared genetics and shared postnatal environment; sibling-comparison and Mendelian randomization studies that eliminated the association entirely would falsify it. Some genetic confounding has in fact been demonstrated — variants that reduce birth weight also independently raise adult cardiometabolic risk — so the honest position is that the developmental contribution is real but smaller than the earliest estimates suggested, and that it operates alongside, not instead of, the polygenic inheritance Chapter 29 describes.

Concept Map to Complete

Copy this onto blank paper and fill every bracket from memory before checking the chapter.

                        FERTILIZATION (ampulla, ~24 h)
                                   │
                     ┌─────────────┴──────────────┐
              [ ___________ ]              [ ___________ ]
              blocks polyspermy            completes [ _______ ]
                    │                              │
                    └──────────┬───────────────────┘
                          ZYGOTE (2n = [ ___ ])
                                │  cleavage: divisions WITHOUT [ ______ ]
                          BLASTOCYST day [ ___ ]
                    ┌───────────┴────────────┐
             [ ____________ ]         [ ______________ ]
                    │                        │
            becomes the [ ______ ]    becomes the [ ______ ]
                    │                        │
         ┌──────────┴─────────┐              ├─ cytotrophoblast
    EPIBLAST            HYPOBLAST            └─ [ _______________ ]
         │                                          secretes [ _____ ]
    gastrulation (day [ ___ ])                      by day 8
         │
   ┌─────┼──────┬────────────┐        PLACENTA — FOUR FUNCTIONS
[ _____ ][ ____ ][ ________ ]         1. [ _____________ ]
   │       │        │                 2. [ _____________ ]
 skin +  muscle,  gut lining,         3. [ _____________ ]
[ _____ ] bone,   [ _____ ],          4. [ _____________ ]
 system  [ ____ ] pancreas
                                      THREE FETAL SHUNTS
   MATERNAL ADAPTATION                ductus [ _______ ] bypasses [ _____ ]
   plasma volume  +[ ___ ]%           foramen [ ______ ] bypasses [ _____ ]
   red cell mass  +[ ___ ]%           ductus [ ________ ] bypasses [ _____ ]
        ↓  therefore                          │
   hemoglobin [ ____ ]  ← because it is       │ at birth, all close because
   a [ _______ ], not a quantity              │ PVR [ ____ ] and SVR [ ____ ]
   cardiac output +[ ___ ]%
   SVR [ _______ ]  → blood pressure [ ______ ]

   PREECLAMPSIA:  failed [ _______________ ] invasion (wk 8–18)
        → spiral arteries keep their [ ____________ ]
        → placental [ ________ ]
        → release of [ _________ ] into maternal blood
        → sequesters [ ______ ] and PlGF
        → systemic [ ___________ ] dysfunction
        → hypertension + [ ___________ ] + HELLP + [ __________ ]

Lab / Self-Exploration

  1. Find the fundus. On a willing pregnant volunteer, or on a diagram, locate the uterine fundus and measure the symphysis–fundal height in centimetres from the pubic symphysis. Between 20 and 36 weeks it approximates gestational age in weeks within ±2 cm. Ask yourself why that relationship breaks down before 20 weeks and after 36.
  2. Feel your own respiratory reserve. Breathe normally, then at the end of a quiet expiration exhale as hard as you can — that extra volume is your expiratory reserve volume, a major component of functional residual capacity. Now imagine 20% of it gone, and oxygen consumption 25% higher. Time how long you can comfortably hold your breath after a normal expiration, and then after a maximal inspiration, and consider what that difference means for airway management in pregnancy.
  3. Build the fetal circulation with string. Lay out six loops of string labelled placenta, liver, right heart, lungs, left heart, and body. Add three short connectors for the shunts. Now cut the placenta loop and close the three connectors in the order given in Figure 28.6, and watch a parallel circuit become a series circuit. Doing this physically fixes the sequence far better than reading it.
  4. Read a real reference range. Find any laboratory report you have access to and locate the reference ranges for hemoglobin, creatinine, and bicarbonate. For each, write down what the pregnancy value should be and why. Then explain to someone why "normal" is a property of a population and a physiological state, not of a number.
  5. Track a positive feedback loop. Over one week, find and write down three positive feedback loops in ordinary life — not physiology. For each, identify what terminates it. Then find one that has no terminator and describe what happens.
  6. Time the let-down reflex. If you have access to a lactating volunteer willing to participate, time the interval from the start of suckling to reported let-down. It is typically 30–60 seconds and shortens with practice as the reflex becomes conditioned. Then ask what would happen to that interval in a noisy, cold, and stressful room, and why.

Key Terms

acrosomal reaction · Exocytosis of the sperm's acrosomal enzymes, triggered by contact with the zona pellucida, which digests a channel through it.

amnion / amniotic fluid · The membrane enclosing the fetus and the fluid it contains, which after 16 weeks is overwhelmingly fetal urine and turns over every ~3 hours.

blastocyst · The day-5 conceptus: an outer trophoblast, a fluid-filled blastocoel, and an inner cell mass.

capacitation · The 6–8 hour maturation of sperm in the female tract that destabilizes the membrane and produces hyperactivated motility; required before fertilization is possible.

chorionic villus · The branching fetal projection into the intervillous space; the unit of placental exchange.

cleavage · The early mitotic divisions that increase cell number without increasing total mass.

cortical reaction · Calcium-triggered exocytosis of cortical granules that cleaves ZP2 and hardens the zona pellucida — the decisive slow block to polyspermy.

critical period · The interval during which a structure is being formed and is therefore susceptible to teratogenic disruption.

decidua · Progesterone-transformed endometrium of pregnancy; its basalis portion forms the maternal side of the placenta.

ductus arteriosus · Fetal shunt from pulmonary trunk to descending aorta, bypassing the lungs; becomes the ligamentum arteriosum.

ductus venosus · Fetal shunt carrying umbilical venous blood past the hepatic sinusoids to the inferior vena cava; becomes the ligamentum venosum.

eclampsia · Seizure in a woman with preeclampsia, caused by cerebral vasogenic edema and loss of autoregulation.

ectoderm / mesoderm / endoderm · The three germ layers, all derived from epiblast at gastrulation.

foramen ovale · Fetal interatrial shunt directing oxygenated inferior caval blood to the left atrium; closes functionally at birth, remaining probe-patent in ~25% of adults.

gastrulation · Formation of the three germ layers from the epiblast via the primitive streak, beginning about day 15.

gestational diabetes · Hyperglycemia first recognized in pregnancy, arising when placenta-driven insulin resistance exceeds maternal beta-cell reserve.

hCG (human chorionic gonadotropin) · Syncytiotrophoblast hormone that rescues the corpus luteum; detected by pregnancy tests; peaks at 8–10 weeks.

hPL (human placental lactogen) · Placental hormone that antagonizes maternal insulin and promotes lipolysis, shunting glucose to the fetus.

HELLP syndrome · Hemolysis, elevated liver enzymes, and low platelets — a severe manifestation of preeclamptic endothelial injury.

implantation · Apposition, adhesion, and invasion of the blastocyst into the endometrium on days 6–7.

inner cell mass (embryoblast) · The blastocyst cell population that forms the entire embryo, amnion, and yolk sac.

lactogenesis II · The onset of copious milk secretion 30–72 hours after delivery, triggered by the fall in progesterone.

living ligature · Contraction of interlacing myometrial fibers around the spiral arteries after placental separation; the mechanism of postpartum hemostasis.

neural tube defect · Failure of neuropore closure by day 25 (cranial → anencephaly) or day 28 (caudal → spina bifida); prevented by periconceptional folate.

neurulation · Formation of the neural tube from neural plate and folds, days 18–28.

notochord · Midline rod derived from the primitive node; induces neurulation and persists as the nucleus pulposus.

physiologic anemia of pregnancy · The fall in hemoglobin concentration produced when plasma volume rises 40–50% while red cell mass rises 20–30%.

placenta · The fetomaternal organ performing exchange, endocrine, immune, and barrier functions; 12–14 m² of villous surface separated from maternal blood by ~2 µm at term.

polyspermy · Fertilization by more than one sperm, producing lethal triploidy; prevented by the fast and slow blocks.

preeclampsia · New-onset hypertension after 20 weeks with proteinuria or end-organ dysfunction, caused by placentally derived antiangiogenic factors producing systemic endothelial dysfunction.

puerperium · The six weeks after delivery, during which pregnancy's adaptations reverse.

sFlt-1 · Soluble VEGF receptor-1 released by the ischemic placenta; sequesters VEGF and PlGF and is the principal mediator of preeclampsia.

spiral artery remodeling · Trophoblast invasion that destroys the smooth muscle of maternal spiral arteries, converting them into wide, low-resistance, non-constricting conduits.

supine hypotensive syndrome · Fall in cardiac output from caval compression by the gravid uterus when the mother lies flat; prevented by left lateral tilt.

surfactant · Alveolar phospholipid film reducing surface tension; produced from ~24 weeks, adequate by 34–36; induced by cortisol.

syncytiotrophoblast · The multinucleate, junction-free outer trophoblast layer that invades the endometrium, secretes placental hormones, and forms the exchange surface.

teratogen · An agent capable of causing a structural or functional birth defect; effect depends on timing, dose, and genotype.

trophoblast · The outer blastocyst layer that becomes the placenta and chorion, contributing nothing to the embryo's body.

zona pellucida · The glycoprotein shell around the oocyte; the sperm's binding target and, after the cortical reaction, the barrier to further sperm.

zygote · The single diploid cell produced by syngamy of the male and female pronuclei.


Next: Chapter 29 · Genetics and Heredity — where the Osei family pedigree is drawn properly, and where "runs in the family" is replaced by a mechanism.